Updated on 2024/12/21

写真a

 
MATSUI Hideaki
 
Organization
Brain Research Institute Center for Bioresources Professor
Title
Professor
▶ display Profile on researchmap
External link

Degree

  • 博士(医学) ( 2010.3   京都大学 )

Research Interests

  • Zebrafish

  • Medaka

  • Neurodegeneration

  • Parkinson's disease

  • Nothobranchius furzeri

  • ヒト剖検脳

  • 神経科学

  • Autism

  • Age-related Diseases

  • Aging

  • Multiple System Atrophy

  • Amyotrophic Lateral Sclerosis

  • Alzheimer's disease

Research Areas

  • Life Science / Neuroscience-general

  • Life Science / Neurology

  • Life Science / Nutrition science and health science

  • Life Science / Molecular biology

Research History (researchmap)

  • Niigata University   Brain Research Institute Center for Bioresources

    2024.3

      More details

  • Niigata University   Brain Research Institute   Vice-Director

    2024.2

      More details

  • Niigata University   Brain Research Institute, Department of Neuroscience of Disease   Professor

    2020.4

      More details

  • Niigata University   Institute for Research Promotion   Professor

    2020.4

      More details

    Country:Japan

    researchmap

  • Niigata University   Department of Neuroscience of disease, Center for Transdisciplinary Research (Brain Research Institute)   Associate Professor

    2016.1 - 2020.3

      More details

  • Niigata University

    2016 - 2020.3

      More details

  • University of Miyazaki   Faculty of Medicine

    2013.1 - 2016.1

      More details

  • TU Braunschweig   Department of CellPhysiology

    2011.1 - 2012.12

      More details

  • 住友病院   神経内科   医員

    2004.6 - 2006.3

      More details

  • 住友病院   総合診療科   医員

    2003.4 - 2004.5

      More details

  • 住友病院   総合診療科   研修医

    2002.6 - 2003.3

      More details

  • 京都大学病院   内科   研修医

    2001.5 - 2002.5

      More details

▶ display all

Research History

  • Niigata University   Brain Research Institute Center for Bioresources   Professor

    2020.4

  • Niigata University   Institute for Research Promotion Center for Transdisciplinary Research   Associate Professor

    2016.1 - 2020.3

Education

  • Kyoto University   Graduate School of Medicine

    2006.4 - 2010.3

      More details

  • Kyoto University   Faculty of Medicine   Department of Medical Science

    1994.4 - 2001.3

      More details

Professional Memberships

Committee Memberships

  • 日本神経科学学会   評議員  

    2023.4   

      More details

    Committee type:Academic society

    researchmap

  • 脳科学関連学会連合   庶務幹事  

    2023.1   

      More details

    Committee type:Academic society

    researchmap

  • NBRP ゼブラフィッシュ   第5期(2022~2026年度)運営委員  

    2022.4   

      More details

    Committee type:Academic society

    researchmap

  • 新潟生化学懇話会   世話人  

    2021.4   

      More details

    Committee type:Academic society

    researchmap

  • 第63回日本神経学会学術大会   年次学術委員  

    2021.1 - 2023.1   

      More details

  • 第43回日本神経科学大会   プログラム委員  

       

      More details

  • 2020年度小型魚類研究会   実行委員  

       

      More details

▶ display all

Qualification acquired

  • Doctor

 

Papers

  • Homozygous slc25a20 Zebrafish Mutant Reveals Insights into Carnitine-Acylcarnitine Translocase Deficiency Pathogenesis. Reviewed

    Ryuichi Hishida, Kohei Ishiguro, Tomoyuki Yamanaka, Shinya Toyokuni, Hideaki Matsui

    Molecular Genetics and Metabolism Reports   41   101165 - 101165   2024.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ymgmr.2024.101165

    researchmap

  • Single housing of juveniles accelerates early-stage growth but extends adult lifespan in African turquoise killifish. Reviewed International journal

    Chika Takahashi, Emiko Okabe, Masanori Nono, Saya Kishimoto, Hideaki Matsui, Tohru Ishitani, Takuya Yamamoto, Masaharu Uno, Eisuke Nishida

    Aging   16   2024.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Within the same species, individuals exhibiting faster growth tend to have shorter lifespans, even if their fast growth arises from early-life pharmacological interventions. However, in vertebrates, the impact of the early-life environment on the growth rate and lifespan has not been fully elucidated. In this study, by utilizing the short-lived African turquoise killifish, which is suitable for a comprehensive life-stage analysis in a brief timeframe, we explored the effects of housing density during the juvenile stage on holistic life traits. As a result, we found that lower housing densities resulted in faster growth, but led to longer adult lifespan, which was contrary to the common notion. Furthermore, the single-housed adult fish displayed a longer egg-laying period than did their group-housed counterparts. Our transcriptome analysis also demonstrated that, in terms of internal transcriptional programs, the life stage progression and aging process of single-housed fish were slower than those of group-housed fish. Collectively, our results suggest that sharing housing with others in early life might influence whole-life attributes, potentially leading to specific life history traits beyond the typical relationship between the growth rate and lifespan.

    DOI: 10.18632/aging.206111

    PubMed

    researchmap

  • Current trends in basic research on Parkinson's disease: from mitochondria, lysosome to α-synuclein. Invited Reviewed International journal

    Hideaki Matsui, Ryosuke Takahashi

    Journal of neural transmission (Vienna, Austria : 1996)   2024.4

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of dopaminergic neurons in the substantia nigra and other brain regions. A key pathological feature of PD is the abnormal accumulation of α-synuclein protein within affected neurons, manifesting as Lewy bodies and Lewy neurites. Despite extensive research efforts spanning several decades, the underlying mechanisms of PD and disease-modifying therapies remain elusive. This review provides an overview of current trends in basic research on PD. Initially, it discusses the involvement of mitochondrial dysfunction in the pathogenesis of PD, followed by insights into the role of lysosomal dysfunction and disruptions in the vesicular transport system. Additionally, it delves into the pathological and physiological roles of α-synuclein, a crucial protein associated with PD pathophysiology. Overall, the purpose of this review is to comprehend the current state of elucidating the intricate mechanisms underlying PD and to outline future directions in understanding this disease.

    DOI: 10.1007/s00702-024-02774-2

    PubMed

    researchmap

  • Extracellular disposal of nuclear waste by APP: a protective mechanism impaired in Alzheimer’s disease

    Godfried Dougnon, Takayoshi Otsuka, Yuka Nakamura, Akiko Sakai, Tomoyuki Yamanaka, Noriko Matsui, Asa Nakahara, Ai Ito, Atsushi Hatano, Masaki Matsumoto, Hironaka Igarashi, Akiyoshi Kakita, Masaki Ueno, Hideaki Matsui

    2024.2

     More details

    Publisher:Cold Spring Harbor Laboratory  

    Abstract

    Although the amyloid beta (Aβ) hypothesis<sup>1</sup>has long been central to Alzheimer’s disease (AD) research, effective therapeutic strategies remain elusive<sup>2,3</sup>. Here we re-evaluate the functions of amyloid precursor protein (APP) and reveal its critical function in protecting against nuclear impairment-induced cell death and inflammation<sup>4,5</sup>. Overexpression of APP mitigated etoposide or lamin A knockdown-induced nuclear damage, while APP removal or mutations exacerbated these effects. Interestingly, neurons differentiated from induced pluripotent stem cells (iPSCs) exhibited similar patterns, and notably, familial AD-associated mutant APP failed to confer protection against nuclear impairment. We identify APP’s interaction with a cytoplasmic structure of nuclear origin, termed “nuclear waste”, and propose its role in extracellular waste disposal. Intriguingly, cells lacking APP showed impaired nuclear waste clearance, leading to abnormal cytoplasmic accumulation of the nuclear waste. Similarly, neuron-specific APP overexpression using adeno-associated virus (AAV) in mice reduced neuronal death and inflammation caused by nuclear damage. Conversely, shRNA-mediated APP exacerbated these effects, and mutant APP associated with familial AD lacked protective effects. Moreover, postmortem analysis of AD brains revealed accumulation of abnormal nuclear waste in the neurocytoplasm, irregular nuclear morphology, and reduced APP levels per neuron. Our data underscore APP’s crucial role in disposing of nuclear waste, maintaining cellular homeostasis, and suggest its dysregulation as a potential contributor to AD pathogenesis. Restoring APP waste clearance in AD could be a promising target for disease-modifying therapies.

    DOI: 10.1101/2024.02.10.579739

    researchmap

  • The Transcription factor NF-YA is Crucial for Neural Progenitor Maintenance during Brain Development. Reviewed International journal

    Tomoyuki Yamanaka, Masaru Kurosawa, Aya Yoshida, Tomomi Shimogori, Akiko Hiyama, Sankar N Maity, Nobutaka Hattori, Hideaki Matsui, Nobuyuki Nukina

    The Journal of biological chemistry   105629 - 105629   2024.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In contrast to stage-specific transcription factors, the role of ubiquitous transcription factors in neuronal development remains a matter of scrutiny. Here, we demonstrated that a ubiquitous factor NF-Y is essential for neural progenitor maintenance during brain morphogenesis. Deletion of the NF-YA subunit in neural progenitors by using nestin-cre transgene in mice resulted in significant abnormalities in brain morphology, including a thinner cerebral cortex and loss of striatum during embryogenesis. Detailed analyses revealed a progressive decline in multiple neural progenitors in the cerebral cortex and ganglionic eminences, accompanied by induced apoptotic cell death and reduced cell proliferation. In neural progenitors, the NF-YA short isoform lacking exon 3 is dominant and co-expressed with cell cycle genes. ChIP-seq analysis from the cortex during early corticogenesis revealed preferential binding of NF-Y to the cell cycle genes, some of which were confirmed to be downregulated following NF-YA deletion. Notably, the NF-YA short isoform disappears and is replaced by its long isoform during neuronal differentiation. Forced expression of the NF-YA long isoform in neural progenitors resulted in a significant decline in neuronal count, possibly due to the suppression of cell proliferation. Collectively, we elucidated a critical role of the NF-YA short isoform in maintaining neural progenitors, possibly by regulating cell proliferation and apoptosis. Moreover, we identified an isoform switch in NF-YA within the neuronal lineage in vivo, which may explain the stage-specific role of NF-Y during neuronal development.

    DOI: 10.1016/j.jbc.2024.105629

    PubMed

    researchmap

  • GPATCH4 contributes to nucleolus morphology and its dysfunction impairs cell viability. Reviewed International journal

    Kazuki Kodera, Ryuichi Hishida, Akiko Sakai, Hiromi Nyuzuki, Noriko Matsui, Tomoyuki Yamanaka, Akihiko Saitoh, Hideaki Matsui

    Biochemical and biophysical research communications   693   149384 - 149384   2023.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The nucleolus serves a multifaceted role encompassing not only rRNA transcription and ribosome synthesis, but also the intricate orchestration of cell cycle regulation and the modulation of cellular senescence. G-patch domain containing 4 (GPATCH4) stands as one among the nucleolar proteins; however, its functional significances remain still unclear. In order to elucidate the functions of GPATCH4, we examined the effects of its dysfunction on cellular proliferation, alterations in nucleolar architecture, apoptotic events, and cellular senescence. Through experimentation conducted on cultured neuroblastoma SH-SY5Y cells, the reduction of GPATCH4 caused inhibition of cellular proliferation, concurrently fostering escalated apoptotic susceptibilities upon exposure to high-dose etoposide. In the realm of nucleolar morphology comparisons, a discernible decline was noted in the count of nucleoli per nucleus, concomitant with a significant expansion in the area occupied by individual nucleoli. Upon induction of senescence prompted by low-dose etoposide, GPATCH4 knockdown resulted in decreased cell viability and increased expression of senescence-associated markers, namely senescence-associated β-galactosidase (SA-β-GAL) and p16. Furthermore, GPATCH4 dysfunction elicited alterations in the gene expression profile of the ribosomal system. In sum, our findings showed that GPATCH4 is a pivotal nucleolar protein that regulates nucleolar morphology and is correlated with cell viability.

    DOI: 10.1016/j.bbrc.2023.149384

    PubMed

    researchmap

  • Modeling familial and sporadic Parkinson's disease in small fishes. Invited Reviewed

    Tomoyuki Yamanaka, Hideaki Matsui

    Development, growth & differentiation   2023.11

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The establishment of animal models for Parkinson's disease (PD) has been challenging. Nevertheless, once established, they will serve as valuable tools for elucidating the causes and pathogenesis of PD, as well as for developing new strategies for its treatment. Following the recent discovery of a series of PD causative genes in familial cases, teleost fishes, including zebrafish and medaka, have often been used to establish genetic PD models because of their ease of breeding and gene manipulation, as well as the high conservation of gene orthologs. Some of the fish lines can recapitulate PD phenotypes, which are often more pronounced than those in rodent genetic models. In addition, a new experimental teleost fish, turquoise killifish, can be used as a sporadic PD model, because it spontaneously manifests age-dependent PD phenotypes. Several PD fish models have already made significant contributions to the discovery of novel PD pathological features, such as cytosolic leakage of mitochondrial DNA and pathogenic phosphorylation in α-synuclein. Therefore, utilizing various PD fish models with distinct degenerative phenotypes will be an effective strategy for identifying emerging facets of PD pathogenesis and therapeutic modalities.

    DOI: 10.1111/dgd.12904

    PubMed

    researchmap

  • Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's disease. Reviewed International journal

    Hideaki Matsui, Shinji Ito, Hideki Matsui, Junko Ito, Ramil Gabdulkhaev, Mika Hirose, Tomoyuki Yamanaka, Akihide Koyama, Taisuke Kato, Maiko Tanaka, Norihito Uemura, Noriko Matsui, Sachiko Hirokawa, Maki Yoshihama, Aki Shimozawa, Shin-Ichiro Kubo, Kenji Iwasaki, Masato Hasegawa, Ryosuke Takahashi, Keisuke Hirai, Akiyoshi Kakita, Osamu Onodera

    Proceedings of the National Academy of Sciences of the United States of America   120 ( 23 )   e2214652120   2023.6

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    α-Synuclein accumulates in Lewy bodies, and this accumulation is a pathological hallmark of Parkinson's disease (PD). Previous studies have indicated a causal role of α-synuclein in the pathogenesis of PD. However, the molecular and cellular mechanisms of α-synuclein toxicity remain elusive. Here, we describe a novel phosphorylation site of α-synuclein at T64 and the detailed characteristics of this post-translational modification. T64 phosphorylation was enhanced in both PD models and human PD brains. T64D phosphomimetic mutation led to distinct oligomer formation, and the structure of the oligomer was similar to that of α-synuclein oligomer with A53T mutation. Such phosphomimetic mutation induced mitochondrial dysfunction, lysosomal disorder, and cell death in cells and neurodegeneration in vivo, indicating a pathogenic role of α-synuclein phosphorylation at T64 in PD.

    DOI: 10.1073/pnas.2214652120

    PubMed

    researchmap

  • Fish Models for Exploring Mitochondrial Dysfunction Affecting Neurodegenerative Disorders Reviewed International journal

    Takayoshi Otsuka, Hideaki Matsui

    International Journal of Molecular Sciences   24 ( 8 )   7079 - 7079   2023.4

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Neurodegenerative disorders are characterized by the progressive loss of neuronal structure or function, resulting in memory loss and movement disorders. Although the detailed pathogenic mechanism has not been elucidated, it is thought to be related to the loss of mitochondrial function in the process of aging. Animal models that mimic the pathology of a disease are essential for understanding human diseases. In recent years, small fish have become ideal vertebrate models for human disease due to their high genetic and histological homology to humans, ease of in vivo imaging, and ease of genetic manipulation. In this review, we first outline the impact of mitochondrial dysfunction on the progression of neurodegenerative diseases. Then, we highlight the advantages of small fish as model organisms, and present examples of previous studies regarding mitochondria-related neuronal disorders. Lastly, we discuss the applicability of the turquoise killifish, a unique model for aging research, as a model for neurodegenerative diseases. Small fish models are expected to advance our understanding of the mitochondrial function in vivo, the pathogenesis of neurodegenerative diseases, and be important tools for developing therapies to treat diseases.

    DOI: 10.3390/ijms24087079

    PubMed

    researchmap

  • Functional regionalization of the differentiating cerebellar Purkinje cell population occurs in an activity-dependent manner. Reviewed International journal

    Alessandro Dorigo, Komali Valishetti, Florian Hetsch, Hideaki Matsui, Jochen C Meier, Kazuhiko Namikawa, Reinhard W Köster

    Frontiers in molecular neuroscience   16   1166900 - 1166900   2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: The cerebellum is organized into functional regions each dedicated to process different motor or sensory inputs for controlling different locomotor behaviors. This functional regionalization is prominent in the evolutionary conserved single-cell layered Purkinje cell (PC) population. Fragmented gene expression domains suggest a genetic organization of PC layer regionalization during cerebellum development. However, the establishment of such functionally specific domains during PC differentiation remained elusive. METHODS AND RESULTS: We show the progressive emergence of functional regionalization of PCs from broad responses to spatially restricted regions in zebrafish by means of in vivo Ca2+-imaging during stereotypic locomotive behavior. Moreover, we reveal that formation of new dendritic spines during cerebellar development using in vivo imaging parallels the time course of functional domain development. Pharmacological as well as cell-type specific optogenetic inhibition of PC neuronal activity results in reduced PC dendritic spine density and an altered stagnant pattern of functional domain formation in the PC layer. DISCUSSION: Hence, our study suggests that functional regionalization of the PC layer is driven by physiological activity of maturing PCs themselves.

    DOI: 10.3389/fnmol.2023.1166900

    PubMed

    researchmap

  • Rapid reverse genetics systems for Nothobranchius furzeri, a suitable model organism to study vertebrate aging Reviewed International journal

    Masayuki Oginuma, Moana Nishida, Tomomi Ohmura-Adachi, Kota Abe, Shohei Ogamino, Chihiro Mogi, Hideaki Matsui, Tohru Ishitani

    Scientific Reports   12 ( 1 )   11628 - 11628   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    The African turquoise killifish Nothobranchius furzeri (N. furzeri) is a useful model organism for studying aging, age-related diseases, and embryonic diapause. CRISPR/Cas9-mediated gene knockout and Tol2 transposon-mediated transgenesis in N. furzeri have been reported previously. However, these methods take time to generate knockout and transgenic fish. In addition, knock-in technology that inserts large DNA fragments as fluorescent reporter constructs into the target gene in N. furzeri has not yet been established. Here, we show that triple-target CRISPR-mediated single gene disruption efficiently produces whole-body biallelic knockout and enables the examination of gene function in the F0 generation. In addition, we developed a method for creating the knock-in reporter N. furzeri without crossing by optimizing the CRISPR/Cas9 system. These methods drastically reduce the duration of experiments, and we think that these advances will accelerate aging and developmental studies using N. furzeri.

    DOI: 10.1038/s41598-022-15972-3

    PubMed

    researchmap

    Other Link: https://www.nature.com/articles/s41598-022-15972-3

  • Cellular response against cytosolic leakage of mitochondrial DNA Reviewed International journal

    Sakai Akiko, Matsui Hideaki

    Neural Regeneration Research   17 ( 12 )   2682 - 2684   2022.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.4103/1673-5374.335816

    PubMed

    researchmap

  • Glutamatergic pathways in the brains of turtles: A comparative perspective among reptiles, birds, and mammals Reviewed International journal

    Mohammad Tufazzal Hussan, Akiko Sakai, Hideaki Matsui

    Frontiers in Neuroanatomy   16   937504 - 937504   2022.8

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Glutamate acts as the main excitatory neurotransmitter in the brain and plays a vital role in physiological and pathological neuronal functions. In mammals, glutamate can cause detrimental excitotoxic effects under anoxic conditions. In contrast, Trachemys scripta, a freshwater turtle, is one of the most anoxia-tolerant animals, being able to survive up to months without oxygen. Therefore, turtles have been investigated to assess the molecular mechanisms of neuroprotective strategies used by them in anoxic conditions, such as maintaining low levels of glutamate, increasing adenosine and GABA, upregulating heat shock proteins, and downregulating K<sub>ATP</sub> channels. These mechanisms of anoxia tolerance of the turtle brain may be applied to finding therapeutics for human glutamatergic neurological disorders such as brain injury or cerebral stroke due to ischemia. Despite the importance of glutamate as a neurotransmitter and of the turtle as an ideal research model, the glutamatergic circuits in the turtle brain remain less described whereas they have been well studied in mammalian and avian brains. In reptiles, particularly in the turtle brain, glutamatergic neurons have been identified by examining the expression of vesicular glutamate transporters (VGLUTs). In certain areas of the brain, some ionotropic glutamate receptors (GluRs) have been immunohistochemically studied, implying that there are glutamatergic target areas. Based on the expression patterns of these glutamate-related molecules and fiber connection data of the turtle brain that is available in the literature, many candidate glutamatergic circuits could be clarified, such as the olfactory circuit, hippocampal–septal pathway, corticostriatal pathway, visual pathway, auditory pathway, and granule cell–Purkinje cell pathway. This review summarizes the probable glutamatergic pathways and the distribution of glutamatergic neurons in the pallium of the turtle brain and compares them with those of avian and mammalian brains. The integrated knowledge of glutamatergic pathways serves as the fundamental basis for further functional studies in the turtle brain, which would provide insights on physiological and pathological mechanisms of glutamate regulation as well as neural circuits in different species.

    DOI: 10.3389/fnana.2022.937504

    PubMed

    researchmap

  • The Utility of Small Fishes for the Genetic Study of Human Age-Related Disorders Reviewed International journal

    Eisuke Dohi, Hideaki Matsui

    Frontiers in Genetics   13   928597 - 928597   2022.7

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Animal models have been used to model human diseases, and among them, small fishes have been highlighted for their usefulness in various ways, such as the low cost of maintenance, ease of genetic modification, small size for easy handling, and strength in imaging studies due to their relative transparency. Recently, the use of turquoise killifish, Nothobranchius furzeri, which is known to exhibit various aging phenotypes in a short period, has attracted attention in research on aging and age-related diseases. However, when using animal models, it is important to keep their genetic background and interspecies differences in mind for translating them into human diseases. In this article, we obtained the gene symbols of protein-coding genes of turquoise killifish, medaka, zebrafish, and humans from NCBI datasets and extracted common shared genes among four species to explore the potential of interspecies translational research and to apply small fish models for human age-related disorders. Common shared protein-coding genes were analyzed with the Reactome Pathway Database to determine the coverage of these genes in each pathway in humans. We applied common shared genes to the Orphanet database to establish a list of human diseases that contain common shared genes among the four species. As examples, the senescence-related pathways and some pathways of human age-related diseases, such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, nonalcoholic fatty liver disease, progeria, hepatocellular carcinoma, and renal cell carcinoma, were extracted from the curated pathway and disease list to discuss the further utility of fish models for human age-related disorders.

    DOI: 10.3389/fgene.2022.928597

    PubMed

    researchmap

  • Modelling Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) Using Mice and Zebrafish Reviewed International journal

    Godfried Dougnon, Hideaki Matsui

    International Journal of Molecular Sciences   23 ( 14 )   7550 - 7550   2022.7

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Autism spectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD) are two debilitating neurodevelopmental disorders. The former is associated with social impairments whereas the latter is associated with inattentiveness, hyperactivity, and impulsivity. There is recent evidence that both disorders are somehow related and that genes may play a large role in these disorders. Despite mounting human and animal research, the neurological pathways underlying ASD and ADHD are still not well understood. Scientists investigate neurodevelopmental disorders by using animal models that have high similarities in genetics and behaviours with humans. Mice have been utilized in neuroscience research as an excellent animal model for a long time; however, the zebrafish has attracted much attention recently, with an increasingly large number of studies using this model. In this review, we first discuss ASD and ADHD aetiology from a general point of view to their characteristics and treatments. We also compare mice and zebrafish for their similarities and discuss their advantages and limitations in neuroscience. Finally, we summarize the most recent and existing research on zebrafish and mouse models of ASD and ADHD. We believe that this review will serve as a unique document providing interesting information to date about these models, thus facilitating research on ASD and ADHD.

    DOI: 10.3390/ijms23147550

    PubMed

    researchmap

  • Loss of GBA in zebrafish leads to dopaminergic neurodegeneration, but overexpression of α-synuclein does not further worsen degeneration. Reviewed International journal

    Kazuki Kodera, Noriko Matsui, Akihiko Saitoh, Hideaki Matsui

    Neuroreport   33 ( 7 )   320 - 325   2022.5

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: Parkinson's disease is a neurodegenerative disorder that causes motor and nonmotor symptoms due to the loss of dopaminergic nerves and is characterized by the presence of Lewy bodies, which are mainly composed of α-synuclein. Glucosylceramidase beta (GBA), which is a causative gene of autosomal recessive Gaucher disease, is also known to be a risk gene for Parkinson's disease. In this study, we tried to detect synergistic effects of α-synuclein accumulation and gba depletion on dopaminergic neurodegeneration in zebrafish. METHODS: We generated a transgenic line of zebrafish overexpressing the A53T α-synuclein and gba mutant fish, and analyzed pathologies of α-synuclein aggregation and neurodegeneration. RESULTS: Zebrafish overexpressing the A53T α-synuclein did not exhibit α-synuclein aggregate formation. After the loss of gba function in this mutant α-synuclein transgenic line, we observed the marked presence of α-synuclein aggregates. Loss of gba function in zebrafish resulted in dopaminergic and noradrenergic neurodegeneration but this level of neurodegeneration was not exacerbated by overexpression of mutant α-synuclein. CONCLUSIONS: These results indicate that loss of gba function was sufficient to generate a neurodegenerative phenotype in zebrafish regardless of the expression of α-synuclein.

    DOI: 10.1097/WNR.0000000000001788

    PubMed

    researchmap

  • Evaluation of Ectopic Mitochondrial DNA in HeLa Cells Reviewed

    Mohammad T. Hussan, Noriko Matsui, Hideaki Matsui

    Current Issues in Molecular Biology   44 ( 3 )   1215 - 1223   2022.3

     More details

    Authorship:Last author, Corresponding author   Publishing type:Research paper (scientific journal)  

    The presence of ectopic DNA in the cytoplasm induces inflammation and cell death. It has been widely reported that leakage of nuclear DNA into the cytoplasm can mainly be sensed by cyclic GMP-AMP synthase (cGAS). We recently reported that mitochondria-derived cytoplasmic double-stranded DNA (dsDNA) that has escaped lysosomal degradation induces significant cytotoxicity in cultured cells and in vivo. Cytoplasmic mitochondrial DNA is assumed to be involved in various diseases and disorders, and more and more papers have been published confirming this. On the other hand, the current method for evaluating mitochondrial DNA in the cytoplasm may not be quantitative. Here, we introduce in detail a method to evaluate ectopic mitochondrial DNA in cells. This method is useful in basic research as well as in the study of aging, Parkinson’s disease, Alzheimer’s disease, heart failure, autoimmune diseases, cancer, and other conditions.

    DOI: 10.3390/cimb44030080

    Scopus

    researchmap

  • Zebrafish, Medaka and Turquoise Killifish for Understanding Human Neurodegenerative/Neurodevelopmental Disorders. Reviewed International journal

    Kazuki Kodera, Hideaki Matsui

    International journal of molecular sciences   23 ( 3 )   2022.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    In recent years, small fishes such as zebrafish and medaka have been widely recognized as model animals. They have high homology in genetics and tissue structure with humans and unique features that mammalian model animals do not have, such as transparency of embryos and larvae, a small body size and ease of experiments, including genetic manipulation. Zebrafish and medaka have been used extensively in the field of neurology, especially to unveil the mechanisms of neurodegenerative diseases such as Parkinson's and Alzheimer's disease, and recently, these fishes have also been utilized to understand neurodevelopmental disorders such as autism spectrum disorder. The turquoise killifish has emerged as a new and unique model animal, especially for ageing research due to its unique life cycle, and this fish also seems to be useful for age-related neurological diseases. These small fishes are excellent animal models for the analysis of human neurological disorders and are expected to play increasing roles in this field. Here, we introduce various applications of these model fishes to improve our understanding of human neurological disorders.

    DOI: 10.3390/ijms23031399

    PubMed

    researchmap

  • Cytosolic dsDNA of mitochondrial origin induces cytotoxicity and neurodegeneration in cellular and zebrafish models of Parkinson’s disease Reviewed International journal

    Hideaki Matsui, Junko Ito, Noriko Matsui, Tamayo Uechi, Osamu Onodera, Akiyoshi Kakita

    Nature Communications   12 ( 1 )   3101 - 3101   2021

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    <title>Abstract</title>Mitochondrial dysfunction and lysosomal dysfunction have been implicated in Parkinson’s disease (PD), but the links between these dysfunctions in PD pathogenesis are still largely unknown. Here we report that cytosolic dsDNA of mitochondrial origin escaping from lysosomal degradation was shown to induce cytotoxicity in cultured cells and PD phenotypes in vivo. The depletion of PINK1, GBA and/or ATP13A2 causes increases in cytosolic dsDNA of mitochondrial origin and induces type I interferon (IFN) responses and cell death in cultured cell lines. These phenotypes are rescued by the overexpression of DNase II, a lysosomal DNase that degrades discarded mitochondrial DNA, or the depletion of IFI16, which acts as a sensor for cytosolic dsDNA of mitochondrial origin. Reducing the abundance of cytosolic dsDNA by overexpressing human DNase II ameliorates movement disorders and dopaminergic cell loss in gba mutant PD model zebrafish. Furthermore, IFI16 and cytosolic dsDNA puncta of mitochondrial origin accumulate in the brain of patients with PD. These results support a common causative role for the cytosolic leakage of mitochondrial DNA in PD pathogenesis.

    DOI: 10.1038/s41467-021-23452-x

    PubMed

    researchmap

    Other Link: http://www.nature.com/articles/s41467-021-23452-x

  • Esophageal High-Resolution Manometry for Diagnosing the Severity of the Chronic Intestinal Pseudo-Obstruction: A Case Series. Reviewed International journal

    Hiroki Sato, Kenya Kamimura, Hideaki Matsui, Takashi Owaki, Shinichi Morita, Yuto Tanaka, Natsuki Ishikawa, Yoshifumi Shimada, Junji Yokoyama, Toshifumi Wakai, Shuji Terai

    Digestive diseases and sciences   66 ( 11 )   3960 - 3967   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Chronic intestinal pseudo-obstruction (CIPO) is a severe and refractory intestinal motility disorder. However, due to its rarity and difficult histological investigation, its pathophysiology has not been characterized. AIM: Therefore, in this study, we aimed to determine the role of esophageal high-resolution manometry (HRM) in CIPO and the histological and clinical characteristics of the disease. METHODS: Patients with CIPO were analyzed for clinical characteristics; histological findings; and clinical courses after therapeutic intervention. In addition, HRM was performed to determine the esophageal involvement. RESULTS: Eleven patients were diagnosed with CIPO, and five required the long period of parenteral nutrition showing impaired esophageal motility including achalasia and absent contractility diagnosed with HRM. The four of these five cases showed acute onset of the CIPO following the triggering events of pregnancy, appendicitis, and surgery. In contrast, other six patients with normal or Jackhammer esophagus on HRM had moderate severity of CIPO with gradual onset. The histological analyses revealed that the loss of the intestinal neural ganglion cells and layers by inflammation, destruction, and atrophy are related to the severity of the clinical course of the disease and esophageal HRM findings of achalasia and absent contractility. CONCLUSIONS: HRM may be useful to diagnose the severity of the clinical course and to determine the therapeutic options for CIPO.

    DOI: 10.1007/s10620-020-06701-9

    PubMed

    researchmap

  • Degeneration of dopaminergic neurons and impaired intracellular trafficking in Atp13a2 deficient zebrafish Reviewed International journal

    Hiromi Nyuzuki, Shinji Ito, Keisuke Nagasaki, Yohei Nitta, Noriko Matsui, Akihiko Saitoh, Hideaki Matsui

    IBRO Reports   9   1 - 8   2020.6

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    ATP13A2 is the autosomal recessive causative gene for juvenile-onset Parkinson's disease (PARK9, Parkinson's disease 9), also known as Kufor-Rakeb syndrome. The disease is characterized by levodopa-responsive Parkinsonism, supranuclear gaze palsy, spasticity, and dementia. Previously, we have reported that Atp13a2 deficient medaka fish showed dopaminergic neurodegeneration and lysosomal dysfunction, indicating that lysosome-autophagy impairment might be one of the key pathogeneses of Parkinson's disease. Here, we established Atp13a2 deficient zebrafish using CRISPR/Cas9 gene editing. We found that the number of TH + neurons in the posterior tuberculum and the locus coeruleus significantly reduced (dopaminergic neurons, 64 % at 4 months and 37 % at 12 months, p < 0.001 and p < 0.05, respectively; norepinephrine neurons, 52 % at 4 months and 40 % at 12 months, p < 0.001 and p < 0.05, respectively) in Atp13a2 deficient zebrafish, proving the degeneration of dopaminergic neurons. In addition, we found the reduction (60 %, p < 0.05) of cathepsin D protein expression in Atp13a2 deficient zebrafish using immunoblot. Transmission electron microscopy analysis using middle diencephalon samples from Atp13a2 deficient zebrafish showed lysosome-like bodies with vesicle accumulation and fingerprint-like structures, suggesting lysosomal dysfunction. Furthermore, a significant reduction (p < 0.001) in protein expression annotated with vesicle fusion with Golgi apparatus in Atp13a2 deficient zebrafish by liquid-chromatography tandem mass spectrometry suggested intracellular trafficking impairment. Therefore, we concluded that Atp13a2 deficient zebrafish exhibited degeneration of dopaminergic neurons, lysosomal dysfunction and the possibility of intracellular trafficking impairment, which would be the key pathogenic mechanism underlying Parkinson's disease.

    DOI: 10.1016/j.ibror.2020.05.002

    PubMed

    researchmap

  • Shrinkage of the myenteric neurons of the small intestine in patients with multiple system atrophy. Reviewed International journal

    Tetsutaro Ozawa, Hiroshi Shimizu, Hideaki Matsui, Osamu Onodera, Akiyoshi Kakita

    Autonomic neuroscience : basic & clinical   221   102583 - 102583   2019.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This study aimed to determine whether enteric neurons are involved in multiple system atrophy (MSA). Four-μm-thick slices of small intestine were prepared from 10%-formalin-fixed and paraffin-embedded materials obtained from autopsied cases. Enteric neurons were stained using an anti-peripherin antibody. Immunostaining of phosphorylated α-synuclein was also performed. Areas of the cytoplasm and nucleus that showed nucleoli were measured using computer software. Both areas of myenteric neurons were significantly smaller in MSA cases (n = 3) than in control subjects (n = 3) (P < 0.0001); however, no deposits of phosphorylated α-synuclein were observed. These findings suggest that myenteric neurons in MSA are affected independent of α-synuclein accumulation.

    DOI: 10.1016/j.autneu.2019.102583

    PubMed

    researchmap

  • Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri. Reviewed International journal

    Hideaki Matsui, Naoya Kenmochi, Kazuhiko Namikawa

    Cell reports   26 ( 7 )   1727 - 1733   2019.2

     More details

    Authorship:Lead author, Corresponding author   Language:English  

    Parkinson's disease (PD) is a neurodegenerative disease characterized by α-synuclein-positive inclusion bodies and loss of neurons, including dopaminergic neurons. Difficulty in replicating PD phenotypes using animal models partly limits the understanding of PD and the therapy required. Although PD is strongly associated with aging, most experimental animals may not exhibit age-related symptoms. Herein, we demonstrate that Nothobranchius furzeri, a rapidly aging teleost with a short life span, exhibits age-dependent degeneration of dopaminergic and noradrenergic neurons and progression of α-synuclein pathologies. These pathological phenotypes are similar to those observed in human patients with PD. Amelioration of the cell loss by genetic depletion of α-synuclein suggests that α-synuclein is not a bystander but a causative protein of neurodegeneration. N. furzeri can reveal mechanisms underlying PD, especially of the idiopathic form that affects a majority of patients with PD, including α-synuclein-dependent neurodegeneration, age-dependent phenotypes, and progression of α-synuclein pathology.

    DOI: 10.1016/j.celrep.2019.01.015

    PubMed

    researchmap

  • Parkinson's disease pathogenesis from the viewpoint of small fish models. Reviewed International journal

    Hideaki Matsui, Ryosuke Takahashi

    Journal of neural transmission (Vienna, Austria : 1996)   125 ( 1 )   25 - 33   2018.1

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Parkinson's disease is a neurodegenerative disorder that involves movement discloses, degeneration of dopaminergic neurons, and presence of cytoplasmic inclusion bodies. Various animal models have been developed and small fish including zebrafish and medaka fish have recently been employed as a new model for Parkinson disease. In this review, we summarize fish models of Parkinson's disease mainly using our own findings and explain two major hypotheses of PD: lysosome dysfunction theory and mitochondrial dysfunction theory. Finally, we discuss the potential for future application of small fish model.

    DOI: 10.1007/s00702-017-1772-1

    PubMed

    researchmap

  • Cerebrospinal fluid injection into adult zebrafish for disease research. Reviewed International journal

    Hideaki Matsui, Noriko Matsui

    Journal of neural transmission (Vienna, Austria : 1996)   124 ( 12 )   1627 - 1633   2017.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER WIEN  

    A modified method of cerebrospinal fluid injection was developed for the efficient and reliable administration of substances to the zebrafish central nervous system. The accuracy of this modified method was evaluated using Alexa Fluor dye injection. A high survival ratio was achieved due to the simplicity of the procedure and ice-tricaine combined anaesthesia. To validate this new method, we injected ammonium chloride, which successfully blocked lysosome function resulting in elevated LC3-II and the accumulation of ubiquitinated proteins. Injection of human α-synuclein fibrils initiated a prion-like propagation of α-synuclein pathology in zebrafish. This method can be used to investigate the effects of various substances and the propagation of α-synuclein in the central nervous system.

    DOI: 10.1007/s00702-017-1787-7

    Web of Science

    PubMed

    researchmap

  • The use of fish models to study human neurological disorders. Invited Reviewed International journal

    Hideaki Matsui

    Neuroscience research   120   1 - 7   2017.7

     More details

    Authorship:Lead author, Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Small teleost fish including zebrafish and medaka have been used as animal models in basic science research due to the relative ease of handling and transparency during embryogenesis. Current advances in genetic engineering and progress in disease genetics allowed utilization of these fish to study neurological diseases and psychiatric disorders. This review summarizes the advantages and disadvantages of using fish for neuropsychiatric research using primarily our own studies as examples. We discuss how fish belong to a class of vertebrates, are feasible for imaging, and include diverse species with multiple research possibilities yet to be discovered.

    DOI: 10.1016/j.neures.2017.02.004

    Web of Science

    PubMed

    researchmap

  • Dopamine system, cerebellum, and nucleus ruber in fish and mammals. Invited Reviewed

    Hideaki Matsui

    Development, growth & differentiation   59 ( 4 )   219 - 227   2017.5

     More details

    Authorship:Lead author, Last author, Corresponding author   Language:English   Publisher:WILEY  

    Small teleost fish including zebrafish and medaka have been used as animal models for research because of their small body size, vast amounts of eggs produced, their rapid development, low husbandry costs, and transparency during embryogenesis. Although the body size and appearance seem different, fish and mammals including human still possess anatomical and functional similarities in their brains. This review summarizes the similarities of brain structures and functions between teleost fish and mammalian brains, focusing on the dopamine system, functional regionalization of the cerebellum, and presence of the nucleus ruber.

    DOI: 10.1111/dgd.12357

    Web of Science

    PubMed

    researchmap

  • Analyzing Synaptic Modulation of Drosophila melanogaster Photoreceptors after Exposure to Prolonged Light. Reviewed International journal

    Atsushi Sugie, Christoph Möhl, Satoko Hakeda-Suzuki, Hideaki Matsui, Takashi Suzuki, Gaia Tavosanis

    Journal of visualized experiments : JoVE   ( 120 )   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JOURNAL OF VISUALIZED EXPERIMENTS  

    The nervous system has the remarkable ability to adapt and respond to various stimuli. This neural adjustment is largely achieved through plasticity at the synaptic level. The Active Zone (AZ) is the region at the presynaptic membrane that mediates neurotransmitter release and is composed of a dense collection of scaffold proteins. AZs of Drosophila melanogaster (Drosophila) photoreceptors undergo molecular remodeling after prolonged exposure to natural ambient light. Thus the level of neuronal activity can rearrange the molecular composition of the AZ and contribute to the regulation of the functional output. Starting from the light exposure set-up preparation to the immunohistochemistry, this protocol details how to quantify the number, the spatial distribution, and the delocalization level of synaptic molecules at AZs in Drosophila photoreceptors. Using image analysis software, clusters of the GFP-fused AZ component Bruchpilot were identified for each R8 photoreceptor (R8) axon terminal. Detected Bruchpilot spots were automatically assigned to individual R8 axons. To calculate the distribution of spot frequency along the axon, we implemented a customized software plugin. Each axon's start-point and end-point were manually defined and the position of each Bruchpilot spot was projected onto the connecting line between start and end-point. Besides the number of Bruchpilot clusters, we also quantified the delocalization level of Bruchpilot-GFP within the clusters. These measurements reflect in detail the spatially resolved synaptic dynamics in a single neuron under different environmental conditions to stimuli.

    DOI: 10.3791/55176

    Web of Science

    PubMed

    researchmap

  • An optimized method for counting dopaminergic neurons in zebrafish. Reviewed International journal

    Hideaki Matsui, Atsushi Sugie

    PloS one   12 ( 9 )   e0184363   2017

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    In recent years, considerable effort has been devoted to the development of a fish model for Parkinson's disease (PD) to examine the pathological mechanisms of neurodegeneration. To effectively evaluate PD pathology, the ability to accurately and reliably count dopaminergic neurons is important. However, there is currently no such standardized method. Due to the relatively small number of dopaminergic neurons in fish, stereological estimation would not be suitable. In addition, serial sectioning requires proficiency to not lose any sections, and it permits double counting due to the large size of some of the dopaminergic neurons. In this study, we report an optimized protocol for staining dopaminergic neurons in zebrafish and provide a reliable counting method. Finally, using our optimized protocol, we confirmed that administration of 6-hydroxydopamine (a neurotoxin) or the deletion of the PINK1 gene (one of the causative genes of familiar PD) in zebrafish caused significant reduction in the number of dopaminergic and noradrenergic neurons. In summary, this method will serve as an important tool for the appropriate evaluation and establishment of fish PD models.

    DOI: 10.1371/journal.pone.0184363

    Web of Science

    PubMed

    researchmap

  • Zebrafish jam-b2 Gal4-enhancer trap line recapitulates endogenous jam-b2 expression in extraocular muscles. Reviewed International journal

    Hideaki Matsui, Alessandro Dorigo, Astrid Buchberger, Jennifer C Hocking, Martin Distel, Reinhard W Köster

    Developmental dynamics : an official publication of the American Association of Anatomists   244 ( 12 )   1574 - 80   2015.12

     More details

    Authorship:Lead author   Language:English  

    BACKGROUND: Members of the junctional adhesion molecule (JAM) family function as cell adhesion molecules and cell surface receptors. The zebrafish genome contains six different jam genes, and jam-b and jam-c were shown to be essential for myoblast fusion during skeletal muscle development. However, little is known about jam-b2 expression and function. RESULTS: We isolated the cDNA of zebrafish jam-b2. jam-b2 is expressed specifically in extraocular muscles (EOMs), jaw muscles, and pectoral fins in zebrafish larvae, but not in trunk muscles. The identified jam-b2 expression pattern is supported by the analysis of a zebrafish Gal4-enhancer trap line, in which the coding sequence of the transcriptional activator KalTA4 together with a Gal4-dependent UAS-mCherry expression cassette was inserted into the jam-b2 locus. Intercrosses with an UAS:EGFP strain proves the possibility for targeting transgene expression to EOMs, jaw muscles and fins. Finally, we characterized the concerted contraction pattern of EOMs in larvae performing an optokinetic response. CONCLUSIONS: The expression pattern of jam-b2 suggests that it may contribute different properties to EOMs, jaw muscles, and pectoral fins. The jam-b2:KalTA4-UAS-mCherry transgenic strain serves a dual role as both a reporter for these muscles and as a valuable genetic tool for targeting transgene expression to EOMs.

    DOI: 10.1002/dvdy.24347

    PubMed

    researchmap

  • Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein. Reviewed International journal

    Norihito Uemura, Masato Koike, Satoshi Ansai, Masato Kinoshita, Tomoko Ishikawa-Fujiwara, Hideaki Matsui, Kiyoshi Naruse, Naoaki Sakamoto, Yasuo Uchiyama, Takeshi Todo, Shunichi Takeda, Hodaka Yamakado, Ryosuke Takahashi

    PLoS genetics   11 ( 4 )   e1005065   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:4  

    Homozygous mutations in the glucocerebrosidase (GBA) gene result in Gaucher disease (GD), the most common lysosomal storage disease. Recent genetic studies have revealed that GBA mutations confer a strong risk for sporadic Parkinson's disease (PD). To investigate how GBA mutations cause PD, we generated GBA nonsense mutant (GBA-/-) medaka that are completely deficient in glucocerebrosidase (GCase) activity. In contrast to the perinatal death in humans and mice lacking GCase activity, GBA-/- medaka survived for months, enabling analysis of the pathological progression. GBA-/- medaka displayed the pathological phenotypes resembling human neuronopathic GD including infiltration of Gaucher cell-like cells into the brains, progressive neuronal loss, and microgliosis. Detailed pathological findings represented lysosomal abnormalities in neurons and alpha-synuclein (α-syn) accumulation in axonal swellings containing autophagosomes. Unexpectedly, disruption of α-syn did not improve the life span, formation of axonal swellings, neuronal loss, or neuroinflammation in GBA-/- medaka. Taken together, the present study revealed GBA-/- medaka as a novel neuronopathic GD model, the pahological mechanisms of α-syn accumulation caused by GCase deficiency, and the minimal contribution of α-syn to the pathogenesis of neuronopathic GD.

    DOI: 10.1371/journal.pgen.1005065

    PubMed

    researchmap

  • Identification of the zebrafish red nucleus using Wheat Germ Agglutinin transneuronal tracing. Reviewed International journal

    Hideaki Matsui, Kazuhiko Namikawa, Reinhard W Köster

    Communicative & integrative biology   7 ( 6 )   e994383   2014.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    The red nucleus is located in the rostral midbrain of the vertebrate brain and controls motor coordination during locomotion. It receives input from the cerebellum and sends its output to the spinal cord. The presence of the red nucleus is well established in tetrapods, and its existence has also been suggested in teleosts but its presence and position has still been under discussion. By using wheat germ agglutinin (WGA) as a genetically encoded anterograde tracer, we recently identified contralateral projections from the cerebellum to a putative red nucleus in the zebrafish midbrain tegmentum. In this report we further revealed red nucleus derived from this contralateral afferent from the cerebellum using WGA and contralateral projections to the hindbrain-spinal cord junction site using DiI-mediated retrograde tracing. Thus the structure that we have identified by anterograde and retrograde tracing fulfills the anatomical demands for the red nucleus: the location in the midbrain tegmentum, contralateral afferent from the cerebellum (cerebello-ruber projection) and contralateral efferent to the spinal cord (rubro-spinal projection).

    DOI: 10.4161/19420889.2014.994383

    PubMed

    researchmap

  • Neuronopathic Gaucher's disease model of medaka displayed axonal accumulation of alpha-synuclein Reviewed

    Uemura Norihito, Takahashi Ryosuke, Koike Masato, Kinoshita Masato, Fujiwara-Ishikawa Tomoko, Matsui Hideaki, Yamakado Hodaka, Uchiyama Yasuo, Todo Takeshi, Takeda Shun-ichi

    MOVEMENT DISORDERS   29   S64   2014.11

     More details

  • Functional regionalization of the teleost cerebellum analyzed in vivo. Reviewed International journal

    Hideaki Matsui, Kazuhiko Namikawa, Andreas Babaryka, Reinhard W Köster

    Proceedings of the National Academy of Sciences of the United States of America   111 ( 32 )   11846 - 51   2014.8

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publisher:32  

    There has been accumulating evidence for a regionalized organization of the cerebellum, which was mostly deduced from anatomical mapping of axonal projections of cerebellar afferents. A likewise regionalization of the cerebellar output has been suggested from lesion studies and dye-tracer experiments, but its physiological targets as well as the functional relevance of such an output regionalization are less clear. Ideally, such functional regionalization should be proven noninvasively in vivo. We here provide evidence for such a regionalization of the output from the cerebellar cortex by genetically encoded transneuronal mapping of efferent circuits of zebrafish Purkinje neurons. These identified circuits correspond to distinct regionalized Purkinje cell activity patterns in freely behaving zebrafish larvae during the performance of cerebellar-dependent behaviors. Furthermore, optogenetic interrogation of selected Purkinje cell regions during animal behavior confirms the functional regionalization of Purkinje cell efferents and reveals their contribution to behavior control as well as their function in controlling lateralized behavioral output. Our findings reveal how brain compartments serve to fulfill a multitude of functions by dedicating specialized efferent circuits to distinct behavioral tasks.

    DOI: 10.1073/pnas.1403105111

    PubMed

    researchmap

  • Exploring the pathogenetic mechanisms underlying Parkinson's disease in medaka fish. Reviewed International journal

    Hideaki Matsui, Norihito Uemura, Hodaka Yamakado, Shunichi Takeda, Ryosuke Takahashi

    Journal of Parkinson's disease   4 ( 2 )   301 - 10   2014

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:2  

    Teleost fish have recently been employed as a model for human neurodegenerative diseases. We used toxin exposure and genetic engineering to develop models of Parkinson's disease (PD) in the teleost fish, medaka. Among the toxins examined, 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), proteasome inhibitors, lysosome inhibitors, and tunicamycin all induced important features of PD in medaka. Specifically, these agents induced dopaminergic cell loss and reduced spontaneous movement, and the latter three toxins produced inclusion bodies that were ubiquitously distributed in the medaka brain. Despite the extensive distribution of these inclusion bodies, the middle diencephalic dopaminergic neurons were particularly susceptible to the effect of the toxins, suggesting that this cluster of dopaminergic neurons is analogous to the human substantia nigra. We have also created a variety of different genetic models using the Targeting Induced Local Lesions in Genomes (TILLING) method, and found that neither PTEN-induced putative kinase 1 (PINK1) mutants nor Parkin mutants disclosed significant dopaminergic cell loss. Surprisingly however, PINK1 and Parkin double mutants exhibited selective dopamine cell loss, as well as aggregation and deficit of mitochondrial activity. Another mutant, the ATP13A2 mutant, also expressed a PD phenotype, exhibiting marked cathepsin D reduction and fingerprint-like structures that are generally found in lysosome storage diseases. Taken together, these data indicate that medaka fish can serve as a new animal model for PD. In this review, we summarize our data and discuss the potential for future application of this animal model.

    DOI: 10.3233/JPD-130289

    PubMed

    researchmap

  • TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency. Reviewed International journal

    Laura J Flinn, Marcus Keatinge, Sandrine Bretaud, Heather Mortiboys, Hideaki Matsui, Elena De Felice, Helen I Woodroof, Lucy Brown, Aimee McTighe, Rosemarie Soellner, Claire E Allen, Paul R Heath, Marta Milo, Miratul M K Muqit, Andreas S Reichert, Reinhard W Köster, Philip W Ingham, Oliver Bandmann

    Annals of neurology   74 ( 6 )   837 - 47   2013.12

     More details

    Language:English   Publisher:6  

    OBJECTIVE: Loss of function mutations in PINK1 typically lead to early onset Parkinson disease (PD). Zebrafish (Danio rerio) are emerging as a powerful new vertebrate model to study neurodegenerative diseases. We used a pink1 mutant (pink(-/-) ) zebrafish line with a premature stop mutation (Y431*) in the PINK1 kinase domain to identify molecular mechanisms leading to mitochondrial dysfunction and loss of dopaminergic neurons in PINK1 deficiency. METHODS: The effect of PINK1 deficiency on the number of dopaminergic neurons, mitochondrial function, and morphology was assessed in both zebrafish embryos and adults. Genome-wide gene expression studies were undertaken to identify novel pathogenic mechanisms. Functional experiments were carried out to further investigate the effect of PINK1 deficiency on early neurodevelopmental mechanisms and microglial activation. RESULTS: PINK1 deficiency results in loss of dopaminergic neurons as well as early impairment of mitochondrial function and morphology in Danio rerio. Expression of TigarB, the zebrafish orthologue of the human, TP53-induced glycolysis and apoptosis regulator TIGAR, was markedly increased in pink(-/-) larvae. Antisense-mediated inactivation of TigarB gave rise to complete normalization of mitochondrial function, with resulting rescue of dopaminergic neurons in pink(-/-) larvae. There was also marked microglial activation in pink(-/-) larvae, but depletion of microglia failed to rescue the dopaminergic neuron loss, arguing against microglial activation being a key factor in the pathogenesis. INTERPRETATION: Pink1(-/-) zebrafish are the first vertebrate model of PINK1 deficiency with loss of dopaminergic neurons. Our study also identifies TIGAR as a promising novel target for disease-modifying therapy in PINK1-related PD.

    DOI: 10.1002/ana.23999

    PubMed

    researchmap

  • PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates. Reviewed International journal

    Hideaki Matsui, Roberto Gavinio, Takeshi Asano, Norihito Uemura, Hidefumi Ito, Yoshihito Taniguchi, Yoshito Kobayashi, Takakuni Maki, Jie Shen, Shunichi Takeda, Kengo Uemura, Hodaka Yamakado, Ryosuke Takahashi

    Human molecular genetics   22 ( 12 )   2423 - 34   2013.6

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:12  

    Parkinson's disease (PD) is a common neurodegenerative disorder characterized by selective dopaminergic cell loss in the substantia nigra, but its pathogenesis remains unclear. The recessively inherited familial PD genes PARK2 and PARK6 have been attributed to mutations in the Parkin and PTEN-induced kinase 1 (PINK1) genes, respectively. Recent reports suggest that PINK1 works upstream of Parkin in the same pathway to regulate mitochondrial dynamics and/or conduct autophagic clearance of damaged mitochondria. This phenomenon is preserved from Drosophila to human cell lines but has not been demonstrated in a vertebrate animal model in vivo. Here, we developed a medaka fish (Oryzias latipes) model that is deficient in Pink1 and Parkin. We found that despite the lack of a conspicuous phenotype in single mutants for Pink1 or Parkin, medaka that are deficient in both genes developed phenotypes similar to that of human PD: late-onset locomotor dysfunction, a decrease in dopamine levels and a selective degeneration of dopaminergic neurons. Further analysis also revealed defects in mitochondrial enzymatic activity as well as cell death. Consistently, PINK1 and Parkin double-deficient MEF showed a further decrease in mitochondrial membrane potential and mitochondrial complex I activity as well as apoptosis compared with single-deficient MEF. Interestingly, these mitochondrial abnormalities in Parkin-deficient MEF were compensated by exogenous PINK1, but not by disease-related mutants. These results suggest that PINK1 and Parkin work in a complementary way to protect dopaminergic neurons by maintaining mitochondrial function in vertebrates.

    DOI: 10.1093/hmg/ddt095

    PubMed

    researchmap

  • ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons. Reviewed International journal

    Hideaki Matsui, Fumiaki Sato, Shigeto Sato, Masato Koike, Yosuke Taruno, Shinji Saiki, Manabu Funayama, Hidefumi Ito, Yoshihito Taniguchi, Norihito Uemura, Atsushi Toyoda, Yoshiyuki Sakaki, Shunichi Takeda, Yasuo Uchiyama, Nobutaka Hattori, Ryosuke Takahashi

    FEBS letters   587 ( 9 )   1316 - 25   2013.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:9  

    Kufor-Rakeb syndrome (KRS) was originally described as an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 was identified as the causative gene in KRS. ATP13A2 encodes the ATP13A2 protein, which is a lysosomal type5 P-type ATPase, and ATP13A2 mutations are linked to autosomal recessive familial parkinsonism. Here, we report that normal ATP13A2 localizes in the lysosome, whereas disease-associated variants remain in the endoplasmic reticulum. Cathepsin D activity was decreased in ATP13A2-knockdown cells that displayed lysosome-like bodies characterized by fingerprint-like structures. Furthermore, an atp13a2 mutation in medaka fish resulted in dopaminergic neuronal death, decreased cathepsin D activity, and fingerprint-like structures in the brain. Based on these results, lysosome abnormality is very likely to be the primary cause of KRS/PARK9.

    DOI: 10.1016/j.febslet.2013.02.046

    PubMed

    researchmap

  • Medaka fish Parkinson's disease model. Reviewed International journal

    Hideaki Matsui, Roberto Gavinio, Ryosuke Takahashi

    Experimental neurobiology   21 ( 3 )   94 - 100   2012.9

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:3  

    The teleost fish has been widely used in creating neurodegenerative models. Here we describe the teleost medaka fish Parkinson's disease (PD) models we developed using toxin treatment and genetic engineering. 1-Methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), proteasome inhibitors, lysosome inhibitors and tunicamycin treatment in our model fish replicated some salient features of PD: selective dopamine cell loss and reduced spontaneous movement with the last three toxins producing inclusion bodies ubiquitously in the brain. Despite the ubiquitous distribution of the inclusion bodies, the middle diencephalic dopaminergic neurons were particularly vulnerable to these toxins, supporting the idea that this dopamine cluster is similar to the human substantia nigra. PTEN-induced putative kinase 1 (PINK1) homozygous mutants also showed reduced spontaneous swimming movements. These data indicate that medaka fish can serve as a new model animal of PD. In this review we summarize our previous data and discuss future prospects.

    DOI: 10.5607/en.2012.21.3.94

    PubMed

    researchmap

  • Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish Reviewed

    Hideaki Matsui, Hidefumi Ito, Yoshihito Taniguchi, Shunichi Takeda, Ryosuke Takahashi

    JOURNAL OF NEUROCHEMISTRY   115 ( 5 )   1150 - 1160   2010.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Perturbations in protein folding and degradation are key pathological mechanisms in neurodegenerative diseases, including Parkinson's disease (PD). Recent evidence suggests that mishandling of proteins may play an important role in the pathogenesis of PD. We have utilized medaka fish to monitor the effects of injecting neurotoxins into the CSF space. In this study, ammonium chloride, tunicamycin, and lactacystin were tested for their ability to disturb lysosomal proteolysis, N-glycosylation in the endoplasmic reticulum, and proteasomal degradation, respectively. All of the substances tested induced selective loss of dopaminergic neurons, movement disorders and inclusion bodies. Among them, the features of the inclusion bodies that developed after ammonium chloride injection mimicked those of PD: co-localization of ubiquitin and phosphorylated alpha-synuclein, as well as the presence of LC3 protein in the inclusion bodies. Our study demonstrated that medaka fish are useful for examining the effects of environmental toxins and lysosome inhibition, and lysosome inhibitors may be factors in the development

    DOI: 10.1111/j.1471-4159.2010.07012.x

    Web of Science

    PubMed

    researchmap

  • Proteasome inhibition in medaka brain induces the features of Parkinson&apos;s disease Reviewed

    Hideaki Matsui, Hidefumi Ito, Yoshihito Taniguchi, Haruhisa Inoue, Shunichi Takeda, Ryosuke Takahashi

    JOURNAL OF NEUROCHEMISTRY   115 ( 1 )   178 - 187   2010.10

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL PUBLISHING, INC  

    P&gt;Recent findings suggest that a defect in the ubiquitin-proteasome system plays an important role in the pathogenesis of Parkinson&apos;s disease (PD). A previous report (McNaught et al. 2004) demonstrated that rats systemically injected with proteasome inhibitors exhibited PD-like clinical symptoms and pathology. However, because these findings have not been consistently replicated, this model is not commonly used to study PD. We used medaka fish to test the effect of systemic administration of proteasome inhibitors because of the high level of accessibility of the cerebrospinal fluid in fish. We injected lactacystin or epoxomicin into the CSF of medaka. With proteasome inhibition in the medaka brain, selective dopaminergic and noradrenergic cell loss was observed. Furthermore, treated fish exhibited reduced spontaneous movement. Treatment with proteasome inhibitors also induced the formation of inclusion bodies resembling Lewy bodies, which are characteristic of PD. Treatment with 6-OHDA also induced dopaminergic cell loss but did not produce inclusion bodies. These findings in medaka are consistent with previous results reporting that non-selective proteasome inhibition replicates the cardinal features of PD: locomotor dysfunction, selective dopaminergic cell loss, and inclusion body formation.

    DOI: 10.1111/j.1471-4159.2010.06918.x

    Web of Science

    PubMed

    researchmap

  • Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement Reviewed

    Hideaki Matsui, Yoshihito Taniguchi, Haruhisa Inoue, Yoshito Kobayashi, Yoshiyuki Sakaki, Atsushi Toyoda, Kengo Uemura, Daisuke Kobayashi, Shunichi Takeda, Ryosuke Takahashi

    NEUROSCIENCE RESEARCH   66 ( 2 )   151 - 161   2010.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Parkinson&apos;s disease is a neurodegenerative disease associated with the degeneration of dopaminergic neurons in the substantia nigra. The PTEN-induced kinase 1 gene (PINK1) is responsible for recessive inherited familial Parkinson&apos;s disease (PARK6). Neither the function of PINK1 nor its role in the prevention of Parkinson&apos;s disease is fully understood. Gene disruption of PINK1 causes remarkably different phenotypes in animal models such as Drosophila melanogaster, zebrafish, and mouse, none of which recapitulate Parkinson&apos;s-disease-like symptoms. We established PINK1-gene-disrupted medaka fish. These mutant fish grew normally at first, then developed significant decrease in the frequency of spontaneous swimming movements in the late-adult stage. Although the mutants did not show any dopaminergic cell loss, the amount of 3,4-dihydroxyphenylacetic acid, a major metabolite of dopamine. decreased. Thus, PINK1 contributes to the maintenance of dopamine metabolism, even before the selective death of dopaminergic neurons. Our animal model is therefore a valuable tool to detect pathogenesis in Parkinson&apos;s patients in the early stages. (C) 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

    DOI: 10.1016/j.neures.2009.10.010

    Web of Science

    PubMed

    researchmap

  • A chemical neurotoxin, MPTP induces Parkinson&apos;s disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish Reviewed

    Hideaki Matsui, Yoshihito Taniguchi, Haruhisa Inoue, Kengo Uemura, Shunichi Takeda, Ryosuke Takahashi

    NEUROSCIENCE RESEARCH   65 ( 3 )   263 - 271   2009.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Parkinson&apos;s disease (PD) is the second most common neurodegenerative disease associated with the degeneration of dopaminergic neurons in the substantia nigra. To create a new model of PD, we used medaka (Oryzias latipes). a small teleost that has been used in genetics and environmental biology. We identified tyrosine hydroxylase (TH) immunopositive dopaminergic and noradrenergic fibers and neurons in the medaka brain. Following establishment of a method for counting the number of dopaminergic neurons and an assay for the evaluation of the medaka behavior. we exposed medaka to 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP). The treatment of medaka at the larval stage, but not at adult stage. decreased the number of dopaminergic cells in the diencephalon and reduced spontaneous movement, which is reminiscent of human PD patients and other MPTP-induced animal PD models. Among TH(+) neurons in the medaka brain, only a specific cluster in the paraventricular area of the middle diencephalon was vulnerable to MPTP toxicity. Detailed examinations of medaka transiently exposed to MPTP at the larval stage revealed that the number of dopaminergic cells was not fully recovered at their adult stage Moreover. the amounts of dopamine persistently decreased in the brain of these MPTP-treated fish MPTP-treated medaka is valuable for modeling human PD. (C) 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

    DOI: 10.1016/j.neures.2009.07.010

    Web of Science

    PubMed

    researchmap

  • Depression in Parkinson's disease - Diffusion tensor imaging study Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Hidekazu Niikawa, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    JOURNAL OF NEUROLOGY   254 ( 9 )   1170 - 1173   2007.9

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:DR DIETRICH STEINKOPFF VERLAG  

    Objectives The pathophysiology of depression and anxiety in Parkinson's disease remains obscure. We aimed to compare the fractional anisotropy (FA) values of Parkinson's disease (PD) patients with and without depression to investigate the nature of depression in PD. Methods Twenty-eight patients were divided into two groups: those with depression and those without. Diagnosis of depression was made using the DSM-IV criteria. Patients in the two groups were matched for Hoehn Yahr stage. Results There were significant reductions in FA values in the bilateral frontal ROIs possibly representing anterior cingulate bundles. Conclusions The anterior cingulate bundles play an important role in depression in PD, and some aspects of depression in PD have pathological processes in common with de novo depression.

    DOI: 10.1007/s00415-006-0236-6

    Web of Science

    PubMed

    researchmap

  • Dementia in Parkinson's disease: diffusion tensor imaging Reviewed

    H. Matsui, K. Nishinaka, M. Oda, H. Niikawa, T. Kubori, F. Udaka

    ACTA NEUROLOGICA SCANDINAVICA   116 ( 3 )   177 - 181   2007.9

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING  

    Objective - Dementia occurs frequently in patients with Parkinson's disease (PD). However, the nature of the dementing process remains controversial. We evaluated various cognitive functions in patients with PD, compared fractional anisotropy (FA) values between PD patients with and without dementia.
    Methods - Thirty-seven consecutive patients with Hoehn-Yahr stage III or IV PD participated in this study. Patients were divided into two groups: (i) PD with dementia group (PDD) and (ii) PD without dementia group (PDND). There were 11 PDD and 26 PDND cases. Ten controls were also studied.
    Results - The PDD group showed significant FA reduction in the bilateral posterior cingulate bundles compared with PDND. FA values in the left posterior cingulate bundle showed significant correlations with many cognitive parameters.
    Interpretation - Our results showed that the posterior cingulate areas play some important roles in the dementing process in PDD. However, as the pathological processes responsible for dementia in PD patients may be multifaceted, further studies are necessary.

    DOI: 10.1111/j.1600-0404.2007.00838.x

    Web of Science

    researchmap

  • Wisconsin card, sorting test in Parkinson's disease: diffusion tensor imaging Reviewed

    H. Matsui, K. Nishinaka, M. Oda, H. Niikawa

    ACTA NEUROLOGICA SCANDINAVICA   116 ( 2 )   108 - 112   2007.8

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING  

    Introduction - It is generally assumed that executive dysfunctions in Parkinson's disease (PD) are caused by degeneration of the basal ganglia or frontal cortex or both. However, there have been few studies investigating the relationship between executive dysfunctions and cerebral pathological change. The objective of this study was to evaluate various cognitive functions in non-demented patients with PD, and to compare the fractional anisotropy (FA) values of PD patients with and without executive dysfunction. Materials and Methods - Twenty-one consecutive non-demented patients with PD were enrolled in this study. Patients were divided into two groups on the basis of their Wisconsin Card Sorting Test score. Results - There was significant FA reduction in the left parietal white matter in the group in which the number of categories achieved was : 2 relative to the group that achieved &gt; 2. Conclusion - Accumulating evidence suggests that conventional 'frontal' tasks correlate with both frontal lobe and parietal lobe function, and we suggest that pathological changes in the left parietal lobe may cause, in part, disturbances in executive tasks in PD.

    DOI: 10.1111/j.1600-0404.2006.00795.x

    Web of Science

    researchmap

  • Trousseau syndrome due to pleural mesothelioma Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Tamotsu Kubori, Fukashi Udaka

    NEUROLOGIST   13 ( 4 )   205 - 208   2007.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Background: Thrombosis involving a brain infarction frequently occurs in patients with a malignant tumor. Although nearly all types of tumor have been reported in association with a hypercoagulable state, pleural mesothelioma-associated Trousseau syndrome is extremely rare.
    Summary: A 69-year-old female was admitted to our hospital with cough, sputum, and breathing difficulties. She was diagnosed as having a mesothelioma from a percutaneous pleural biopsy. Although there were no risk factors for atherosclerosis, brain infarctions showed frequent relapses, even under anticoagulant therapy, and there was a marked hypercoagulable state.
    Conclusion: Attention should be paid to this syndrome when unexplained brain infarctions occur in patients with pleural mesothelioma.

    DOI: 10.1097/01.nrl.0000253113.53846.ec

    Web of Science

    PubMed

    researchmap

  • Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Narihiro Hara, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    PARKINSONISM & RELATED DISORDERS   13 ( 3 )   174 - 181   2007

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Background: Nature of the dementing process in Parkinson's disease, and particularly its relationship with Alzheimer's disease, diffuse Lewy body disease or frontal dementia remains controversial.
    Objective: We hypothesize that origins of dementia in Parkinson's disease are heterogeneous, so we compared cortical regional cerebral blood flow (rCBF) between Parkinson's disease patients with and without dementia.
    Patients: Forty consecutive patients with Hoehn-Yahr stage III or IV Parkinson's disease were used (13 patients had dementia (PDD group), and 27 patients had no dementia (PDND group)).
    Results: There were significant rCBF reductions in the left parietal association cortex and left frontal association cortex in PDD. Multiple logistic regression analysis demonstrated that only rCBF of the left frontal association cortex was significant. PDD patients were divided into three groups according to rCBF patterns: frontal hypoperfusion group, Alzheimer's disease-like group, and diffuse Lewy body disease-like group.
    Conclusions: Controversial study results involving PDD patients may be mainly due to heterogeneity in dementing processes in Parkinson's disease. (c) 2006 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.parkreldis.2006.10.005

    Web of Science

    PubMed

    researchmap

  • Thalamic hyperperfusion in verbal hallucination of parkinsonian patients Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Takafumi Miyoshi, Narihiro Hara, Masaya Oda, Tamotsu Kubori, Fukashi Udaka

    INTERNAL MEDICINE   46 ( 21 )   1765 - 1769   2007

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC INTERNAL MEDICINE  

    Objective We compared brain perfusion image using 3D-SSP analysis of I-123-IMP SPECT between Parkinson's disease patients with auditory verbal hallucination and those without auditory hallucination.
    Methods Eighty-three cases with Parkinson's disease were studied. In 6 of these patients, auditory hallucination was noted. Among them, four cases had verbal hallucination and two other cases had elementary hallucination. Auditory hallucination was not found in the other 77 cases.
    Results Right thalamic perfusion was significantly increased in the verbal hallucination group compared to the group that lacked auditory hallucination.
    Conclusion In Parkinson's disease, the right thalamic hyperactive state may be related to verbal hallucination.

    DOI: 10.2169/internalmedicine.46.0191

    Web of Science

    PubMed

    researchmap

  • Auditory event-related potentials in Parkinson's disease: Prominent correlation with attention Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Tamotsu Kubori, Fukashi Udaka

    PARKINSONISM & RELATED DISORDERS   13 ( 7 )   394 - 398   2007

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Objective: Auditory P300 has been reported to be abnormal in demented patients with Parkinson's disease. However, it is still controversial which factors in Parkinson's disease influence P300 parameters. Methods: Forty patients with Parkinson's disease were included. Patients were divided into two groups: patients with dementia (PDD) and without dementia (PDND). An `odd-ball' paradigm was used for auditory event-related potentials. Results: P300 latency was markedly delayed in PDD patients. Age and DRSI (attention) were the most important factors influencing P300 latency. Conclusions: Although there have been reports of P300 in the past, its abnormalities reflect the deficit of attention in Parkinson's disease. (C) 2007 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.parkreldis.2006.12.012

    Web of Science

    PubMed

    researchmap

  • Adult onset hemiparkinsonism with brain hemihypoplasia Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    NEUROLOGY INDIA   54 ( 4 )   450 - 451   2006.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publisher:NEUROL SOC INDIA  

    DOI: 10.4103/0028-3886.28136

    Web of Science

    PubMed

    researchmap

  • Hypoperfusion of the auditory and prefrontal cortices in parkinsonian patients with verbal hallucinations Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Narihiro Hara, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    MOVEMENT DISORDERS   21 ( 12 )   2165 - 2169   2006.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    We examined patients with and without auditory hallucinations, using n-isopropyl-p-[I-123] iodoamphetarnine single photon emission computed tomographic imaging. We assessed verbal hallucinations in the present study: patients with nonverbal auditory hallucinations were excluded. A total of 11 patients with verbal and visual hallucinations and 17 patients with visual hallucinations only were enrolled. Patients with both verbal and visual hallucinations revealed significant hypoperfusion in the bilateral prefrontal cortex and right superior temporal gyrus compared to patients with visual hallucinations only. There were no significant hyperperfusion in patients with verbal plus visual hallucinations. These results may support the release hallucination theory in verbal hallucinations of Parkinson's disease, although another explanations may be more appropriate and further studies are required. (C) 2006 Movement Disorder Society.

    DOI: 10.1002/mds.21147

    Web of Science

    PubMed

    researchmap

  • Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Narihiro Hara, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    MOVEMENT DISORDERS   21 ( 12 )   2140 - 2144   2006.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    Little is known about the developing mechanisms of visual hallucinations in Parkinson's disease. This study aimed to investigate perfusion changes in parkinsonian patients with visual hallucinations using n-isopropyl-p-[I-123]iodoamphetamine ([I-123]IMP) single photon emission computed tomography imaging. A total of 70 consecutive patients, including 31 patients with visual hallucinations, and 39 patients without hallucinations, participated in this study. Patients with severe cognitive impairment (Mini-Mental State Examination score &lt; 20), nonvisual hallucinations, or confusion were excluded. We compared brain perfusion changes between the two groups. We found that hallucinatory patients had significant perfusion reductions in the bilateral inferior parietal lobule, inferior temporal gyrus, precuneus gyrus, and occipital cortex compared to nonhallucinatory patients. These results suggested that hypoperfusion of the visual pathway was closely related to visual hallucinations in Parkinson's disease. (C) 2006 Movement Disorder Society.

    DOI: 10.1002/mds.21140

    Web of Science

    PubMed

    researchmap

  • Minor depression and brain perfusion images in Parkinson's disease Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    MOVEMENT DISORDERS   21 ( 8 )   1169 - 1174   2006.8

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    Depression is common in individuals with Parkinson's disease. However, the pathophysiology of depression in Parkinson's disease remains obscure. Here we compared brain perfusion images of Parkinson's disease patients with and without depression to investigate correlations between depression and brain perfusion images in Parkinson's disease. We divided 40 consecutive patients with Parkinson's disease into two groups: patients with minor depression (n = 22) and patients without depression (n = 18). We then compared brain perfusion images between the two groups. As a result, hypoperfusion of the left superior and inferior frontal gyrus was demonstrated in depressed patients. These results were partially in agreement with previous studies on de novo and parkinsonian major depression. We could not conclude on whether pathophysiological mechanisms differed between de novo depression and depression with Parkinson's disease, and between major and minor depressions. (C) 2006 Movement Disorder Society.

    DOI: 10.1002/mds.20923

    Web of Science

    PubMed

    researchmap

  • Excessive daytime sleepiness in Parkinson disease: A SPECT study Reviewed

    Hideaki Matsui, Kazuto Nishinaka, Masaya Oda, Narihiro Hara, Kenichi Komatsu, Tamotsu Kubori, Fukashi Udaka

    SLEEP   29 ( 7 )   917 - 920   2006.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ACADEMY SLEEP MEDICINE  

    Study Objectives: The underlying pathologic mechanism of excessive daytime sleepiness (EDS) in Parkinson disease and the relative contributions of brain function to this process are poorly understood. We compared brain perfusion images between patients with Parkinson disease and EDS and those without EDS using n-isopropyl-p-123I iodoamphetamine single photon emission computed tomography. Design: Clinical study. Setting: Sumitomo Hospital. Patients: Thirteen patients with Parkinson disease with EDS (EDS group) and 27 patients with Parkinson disease without EDS (no-EDS group) were studied. Whether or not each case had EDS was determined according to the response to the Epworth Sleepiness Scale: patients with an Epworth Sleepiness Scale score &gt;= 10 were included in the EDS group, and patients with an Epworth Sleepiness Scale score :5 9 were included in the no-EDS group. Measurements and Results: There were significant hypoperfusions in the left parietal and temporal association cortex in the EDS group, In the multivariable logistic regression model, attention and decreased regional cerebral blood flow of the left parietal association cortex and right caudate and increased regional cerebral blood flow of the right thalamus were the independent and significant factors. Conclusions: The cortical hypofunction relative to hyperfunction of the brain stem may relate to EDS in Parkinson disease. This is the first imaging study about EDS in Parkinson disease, and further studies are required.

    Web of Science

    PubMed

    researchmap

  • Frontal assessment battery and brain perfusion image in Parkinson's disease Reviewed

    H Matsui, F Udaka, T Miyoshi, N Hara, A Tamura, M Oda, T Kubori, K Nishinaka, M Kameyama

    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY   19 ( 1 )   41 - 45   2006.3

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:SAGE PUBLICATIONS INC  

    The objective was to compare brain perfusion image using 3-dimensional stereotactic surface projection analysis of N-isopropyl-p-I-123 iodoamphetamine single photon emission computed tomography between Parkinson's disease patients with a high frontal assessment battery score and those with a low frontal assessment battery score. Thirty nondemented patients with Parkinson's disease were studied. Patients were divided into 2 groups: a high-scoring group whose frontal assessment battery score was 12 or more and a low-scoring group whose frontal assessment battery score was 11 or less. The high-scoring group included 21 patients, and the low-scoring group included 9 patients. They underwent N-isopropyl-p-I-123 iodoamphetamine single photon emission computed tomography, and we analyzed the data by the 3-dimensional stereotactic surface projection method. Results showed that left inferior parietal lobule and left supramarginal gyrus perfusion of the low-scoring group were significantly decreased compared with the high-scoring group. It is concluded that-patients with Parkinson's disease may have frontal lobe dysfunction, but the decreased frontal assessment battery score may be caused not by progressed frontal lobe dysfunction but by parietal lobe dysfunction added to their preexisting frontal lobe impairment.

    DOI: 10.1177/0891988705284714

    Web of Science

    PubMed

    researchmap

  • Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease Reviewed

    H Matsui, F Udaka, M Oda, T Kubori, K Nishinaka, M Kameyama

    NEUROLOGY INDIA   54 ( 1 )   83 - 85   2006.3

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NEUROL SOC INDIA  

    We described a 69-year-old woman with neurological manifestations due to mixed connective tissue disease (MCTD). The patient demonstrated subacute cognitive decline, seizure and gait disturbance with no connective tissue manifestation. She had been diagnosed with dementia at another hospital, later in our hospital, serological examinations disclosed high titers of anti-RNP antibody. Cognitive dysfunction in this patient was dramatically ameliorated by steroid therapy. Three months later, she developed edema of the hands, synovitis and acrosclerosis. The patient was finally diagnosed as having MCTD. We emphasized MCTD as a rare cause of "treatable dementia".

    Web of Science

    PubMed

    researchmap

  • HTLV-I-associated peripheral neuropathy with smoldering-type adult T-cell leukemia Reviewed

    H Matsui, F Udaka, T Kubori, M Oda, K Nishinaka, N Oka

    NEUROLOGIST   12 ( 2 )   109 - 113   2006.3

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Background: Peripheral neuropathy with adult T-cell leukemia/ lymphoma (ATLL) has seldom been reported.
    Review Summary: A 69-year-old woman with smoldering-type ATLL presented with pain and muscle weakness of the bilateral upper and lower limbs and gait disturbance. Anti-human T lymphotropic virus type I antibody was positive in the serum but negative in the cerebrospinal fluid. Magnetic resonance imaging (MRI) showed no abnormal signals in the spinal cord or brain. Nerve conduction Studies disclosed severe peripheral neuropathy. Sural nerve biopsy disclosed both axonal degeneration and demyelinated fibers, and marked perivascular inflammatory infiltrates mainly consisting of T lymphocytes without malignant changes were seen. Steroid therapy was markedly effective, and the patient became able to walk without assistance.
    Conclusions: This is the first reported case of ATLL and peripheral neuropathy in which a nerve biopsy was performed. In our patient, the marked perivascular inflammatory infiltrates mainly consisting of T lymphocytes suggested either immune-mediated vasculitis or tumor invasion. Further studies are needed.

    DOI: 10.1097/01.nrl.0000202598.81422.36

    Web of Science

    PubMed

    researchmap

  • Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease Reviewed

    H Matsui, F Udaka, A Tamura, M Oda, T Kubori, K Nishinaka, M Kameyama

    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY   19 ( 1 )   36 - 40   2006.3

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:SAGE PUBLICATIONS INC  

    Pathophysiology of hallucinations in Parkinson's disease is poorly understood. This study investigated relationships between visual hallucinations and visual acuity. Twenty-six consecutive patients with Parkinson's disease participated in this study. Patients were divided into two groups: patients with visual hallucinations (VH group) and those without visual hallucinations (no-VH group). Unaided and corrected eyesight was evaluated in all patients, and if frequent use of prescription glasses or contact lenses was involved, eyesight using these lenses was also measured as the patient's own best eyesight. If a patient did not use prescription glasses or contact lenses, the patient's own best eyesight was defined as the unaided eyesight. Multivariate regression analysis demonstrated that agonist use and best eyesight were different after the backward elimination method. Visual hallucinations were closely related not to uncorrected eyesight or unaided eyesight but to the patient's best eyesight. It is suggested that impaired visual acuity is a risk factor for visual hallucinations.

    DOI: 10.1177/0891988705284739

    Web of Science

    PubMed

    researchmap

  • Wisconsin Card Sorting Test and brain perfusion imaging in Parkinson's disease Reviewed

    H Matsui, K Nishinaka, M Oda, N Hara, K Komatsu, T Kubori, F Udaka

    PARKINSONISM & RELATED DISORDERS   12 ( 5 )   273 - 278   2006

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Background: Few imaging studies investigated frontal dysfunctions in Parkinson's disease.
    Objectives: We investigated relationships between Wisconsin Card Sorting Test (WCST) and brain perfusion in patients with non-demented Parkinson's disease.
    Methods: Patients were divided into two groups according to WCST score: (1) CA (number of category achieved) &lt;= 2 or (2) CA &gt;= 3. We performed three-dimensional stereotactic surface projection and volume of interest analysis using I-123-IMp scintigraphy.
    Results: Hypoperfusions of the bilateral posterior cingulate, rostrodorsal prefrontal, and left frontopolar cortices were shown in CA &lt;= 2 group, with the left cingulate and right rostrodorsal prefrontal cortices showing prominent hypoperfusion. CA and PE (perseverative errors) scores significantly correlated with perfusion of the left posterior cingulate cortex. PE score also correlated with perfusion of the right rostrodorsal prefrontal cortex.
    Conclusion: Data indicated participations of various regions in task achievement. Careful interpretation of WCST scores is required. (c) 2006 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.parkreldis.2005.12.006

    Web of Science

    PubMed

    researchmap

  • Parkinson's disease following panic disorder Reviewed

    Hideaki Matsui, Fukashi Udaka, Masaya Oda, Akiko Tamura, Tamotsu Kubori, Kazuto Nishinaka, Masakuni Kameyama

    Journal of Neuropsychiatry and Clinical Neurosciences   18 ( 1 )   130   2006

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publisher:American Psychiatric Publishing Inc.  

    DOI: 10.1176/jnp.18.1.130

    Scopus

    PubMed

    researchmap

  • A case of Parkinson's disease with L-dopa-evoked catalepsy Reviewed

    Hirohide Asai, Fukashi Udaka, Naoya Oishi, Masaya Oda, Hideaki Matsui, Tamotsu Kubori, Kazuto Nishinaka, Yoshiko Furiya, Satoshi Ueno, Masakuni Kameyama

    PARKINSONISM & RELATED DISORDERS   12   S91 - S91   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    DOI: 10.1016/j.parkreldis.2006.05.020

    Web of Science

    researchmap

  • Disruptions of the fornix fiber in parkinsonian patients with excessive daytime sleepiness Reviewed

    H Matsui, K Nishinaka, M Oda, H Niikawa, K Komatsu, T Kubori, F Udaka

    PARKINSONISM & RELATED DISORDERS   12 ( 5 )   319 - 322   2006

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Background: Although excessive daytime sleepiness (EDS) in Parkinson's disease (PD) has received a great deal of attention, the underlying pathological mechanism of its development and the relative contributions of brain function to this process are poorly understood.
    Objective: To compare the fractional anisotropy (FA) values of PD patients with EDS and those without EDS, and to investigate the mechanism of EDS in this disease.
    Methods: Eleven patients with PD with EDS, 26 patients with PD without EDS and 10 controls participated in this study. Patients with an ESS (Epworth Sleepiness Scale) score &gt;= 10 were defined as having EDS. The FA values of 5 regions of interest (ROI) including the fornix were compared between the three groups.
    Results: There were significant reductions in FA values of the fornix fiber in patients with EDS. ESS scores had significant correlation with FA values of the fornix.
    Conclusions: Our study is the first to find the fornix fiber degeneration in PD patients with EDS. These results indicate that fornix dysfunction may have some correlations with EDS in PD. (c) 2006 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.parkreldis.2006.01.007

    Web of Science

    PubMed

    researchmap

  • Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms? Reviewed

    H Matsui, K Nishinaka, M Oda, K Komatsu, T Kubori, F Udaka

    PARKINSONISM & RELATED DISORDERS   12 ( 5 )   284 - 288   2006

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Objectives: To compare MIBG (metaiodobenzylguanidine) uptake between Parkinson's disease patients with and without autonomic symptoms to investigate meanings of MIBG scintigraphy and correlations between autonomic symptoms and MIBG uptake.
    Methods: Forty consecutive patients with Hoehn-Yahr III or IV Parkinson's disease and 12 controls were enrolled. We compared cardiac MIBG uptake between patients with and without orthostatic hypotension. Similar comparisons were performed for constipation and bladder dysfunction.
    Results: MIBG uptake did not significantly correlate with age, disease duration, Hoehn-Yahr stage, Unified Parkinson's Disease Rating Scale (UPDRS) motor score or levodopa equivalent daily doses. There were no significant correlations between orthostatic hypotension/constipation and cardiac MIBG uptake. Only bladder symptoms significantly correlated with MIBG uptake.
    Conclusion: Meanings of MIBG uptake abnormalities in Parkinson's disease and relationship between MIBG uptake and clinical parameters remain to be resolved in future studies. (c) 2006 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.parkreldis.2005.12.008

    Web of Science

    PubMed

    researchmap

  • Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease Reviewed

    H Matsui, F Udaka, T Miyoshi, N Hara, A Tamaura, M Oda, T Kubori, K Nishinaka, M Kameyama

    MOVEMENT DISORDERS   20 ( 10 )   1272 - 1277   2005.10

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    Gait disturbance is a cardinal symptom in patients with Parkinson's disease. Among the gait disturbances, freezing of gait is a unique and troublesome symptom, but its mechanism is unclear. We compared brain perfusion images using three-dimensional stereotactic surface projection analysis of N-isopropyl-p-(123)] iodoamphetamine single photon emission computed tomography between Parkinson's disease patients with freezing of gait and those without. Twenty-four cases (freezing of gait group) with Parkinson's disease with freezing of gait, and 31 Hoehn and Yahr stage-matched cases (no freezing of gait group) with Parkinson's disease without freezing of gait were studied. Bilateral Brodmann area I I perfusion of the freezing of gait group decreased significantly compared to that of the no freezing of gait group. The Brodmann area 11 may play important roles in gait, and impairment in this region may have a close relationship with freezing of gait in Parkinson's disease. (c) 2005 Movement Disorder Society.

    DOI: 10.1002/mds.20520

    Web of Science

    PubMed

    researchmap

  • N-isopropyl-p-I-123 iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia Reviewed

    H Matsui, F Udaka, T Miyoshi, N Hara, A Tamura

    INTERNAL MEDICINE   44 ( 10 )   1046 - 1050   2005.10

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC INTERNAL MEDICINE  

    Background Intellectual deterioration occurs in 10-40% of patients with Parkinson's disease. However, there are many conflicting studies on its relation with brain perfusion and the nature of this dementing process remains controversial.
    Objective To compare cortical perfusion by SPECT using I-123-IMP between Parkinson's disease patients with dementia and those without dementia and to investigate the correlation between dementia in Parkinson's disease and brain perfusion in various areas.
    Methods Fifty-two cases of Parkinson's disease and 10 control cases were studied. The Parkinson's disease with dementia group included 30 cases and the Parkinson's disease without dementia group included 22 cases. Results By multiple logistic regression method, we demonstrated significant hypoperfusion in the occipital cortex in Parkinson's disease with dementia.
    Conclusions The cause of dementia in Parkinson's disease may vary. We demonstrated that occipital hypoperfusion was closely correlated to dementia in Parkinson's disease compared to frontal, parietal and temporal perfusion.

    DOI: 10.2169/internalmedicine.44.1046

    Web of Science

    PubMed

    researchmap

  • Multiple sclerosis following splenectomy as a treatment for idiopathic thrombocytopenic purpura Reviewed

    H Matsui, F Udaka, A Tamura, M Oda, T Kubori, K Nishinaka, M Kameyama

    INTERNAL MEDICINE   44 ( 7 )   747 - 749   2005.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC INTERNAL MEDICINE  

    A 27-year-old woman was admitted to our hospital with tetraparesis, dysesthesia and hypoesthesia of all regions below the breasts, urinary disturbance, and difficulty in breathing. Since age 21 idiopathic thrombocytopenic purpura (ITP) was diagnosed and steroid therapy was continued. At age 26, she had splenectomy for her ITP. On admission, steroid pulse therapy was administered with a tentative diagnosis of transverse myelitis. Symptoms gradually ameliorated. At age 29, she gradually lost her left vision, and multiple sclerosis was diagnosed and steroid therapy was administered, and her left vision gradually ameliorated. There are several reports describing other autoimmune disorders that arise after splenectomy. Since the spleen acts as a major pool of type 2 helper T cells, it is plausible that peripheral type 1 helper T cell activity may increase after splenectomy, promoting the development of autoimmune disorders. We considered there would be a close relation between splenectomy for ITP and multiple sclerosis in this case.

    DOI: 10.2169/internalmedicine.44.747

    Web of Science

    PubMed

    researchmap

  • Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson's disease Reviewed

    H Matsui, F Udaka, T Miyoshi, N Hara, A Tamura, M Oda, T Kubori, K Nishinaka, M Kameyama

    ACTA NEUROLOGICA SCANDINAVICA   112 ( 1 )   36 - 41   2005.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING  

    Objective - To compare brain perfusion image using three-dimensional stereotactic surface projection (3D-SSP) analysis of N-isopropyl-p-I-123 iodoamphetamine (I-123-IMp) single photon emission computed With tomography (SPECT) between patients with Parkinson's disease orthostatic hypotension and those without orthostatic hypotension. Materials and methods -Fifteen patients with Parkinson's disease and orthostatic hypotension and 13 patients with Parkinson's disease without orthostatic hypotension were studied. We compared brain perfusion image between the two groups by 3D-SSP. Results-Bilateral anterior cingulate gyrus perfusion of the patients with orthostatic hypotension was significantly decreased compared to that of the patients without orthostatic hypotension. Conclusions - The disorder of anterior cingulate gyrus may participate in the autonomic failure in Parkinson's disease.

    DOI: 10.1111/j.1600-0404.2005.00427.x

    Web of Science

    Scopus

    PubMed

    researchmap

  • Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features Reviewed

    H Matsui, F Udaka, T Miyoshi, N Hara, A Tamura, M Oda, T Kubori, K Nishinaka, M Kameyama

    PARKINSONISM & RELATED DISORDERS   11 ( 4 )   227 - 232   2005.6

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    Background: The patterns of regional cerebral blood flow in Parkinson's disease and multiple system atrophy remain inconsistent.
    Objectives: To compare brain perfusion images of I-123-IMP SPECT between Parkinson's disease, multiple system atrophy with predominant parkinsonian features (MSA-P) and controls.
    Methods: Eighty-two patients with Parkinson's disease, 10 patients with MSA-P and 14 controls were studied. We performed 3D-SSP and volume of interest analysis using I-123-IMP scintigraphy.
    Results: Occipital perfusion of MSA-P increased compared to that of Parkinson's disease and perfusion in the cerebellum and primary sensorimotor cortex of Parkinson's disease increased compared to that of MSA-P. Perfusion in the putamen of MSA-P decreased compared to that of Parkinson's disease.
    Conclusion: Our study demonstrated perfusion differences in I-123-IMP SPECT between the two diseases. &COPY; 2005 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.parkreldis.2005.01.001

    Web of Science

    PubMed

    researchmap

  • Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid Reviewed

    H Matsui, F Udaka, M Oda, A Tamura, T Kubori, K Nishinaka, M Kameyama

    ANNALS OF NUCLEAR MEDICINE   19 ( 3 )   225 - 229   2005.5

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPANESE SOCIETY NUCLEAR MEDICINE  

    Background: Decreased cardiac metaiodobenzylguanidine (MIBG) uptake was reported in Parkinson's disease and this contributes to the differential diagnosis between Parkinson's disease and other forms of parkinsonism such as multiple system atrophy. However, decreased MIBG uptake of the thyroid has not been demonstrated. Objective: To compare MIBG uptake of the thyroid among Parkinson's disease, multiple system atrophy and controls. Methods: Twenty-six patients with Parkinson's disease, 11 patients with multiple system atrophy and 14 controls were examined in this study. Planar images were taken 15 minutes (early images) and 3 hours (late images) after intravenous injection of 111 MBq 123 I-MIBG. Results: MIBG uptake of the thyroid on early images decreased significantly in Parkinson's disease compared to controls (p &lt; 0.0001) and multiple system atrophy (p = 0.018). MIBG uptake of the thyroid on early images decreased significantly also in multiple system atrophy compared to controls (p = 0.027). On late images, thyroid uptake differed significantly only between Parkinson's disease and controls (p = 0.010). Conclusions: Our study is the first to demonstrate decreased MIBG uptake of the thyroid in Parkinson's disease. Sympathetic nervous denervation of Parkinson's disease occurred not only in the heart but also in the thyroid.

    Web of Science

    PubMed

    researchmap

  • Persistent primitive hypoglossal artery with atrial septal defect Reviewed

    H Matsui, F Udaka, T Kubori, M Oda, K Nishinaka, M Kameyama

    INTERNAL MEDICINE   44 ( 5 )   507 - 508   2005.5

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.44.507

    Web of Science

    PubMed

    researchmap

  • Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy Reviewed

    H Matsui, F Udaka, M Oda, T Kubori, K Nishinaka, M Kameyama

    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL   119 ( 1 )   56 - 60   2005.4

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    We compared MIBG uptake at various parts of the body in controls and patients with Parkinson's disease and multiple system atrophy. In the heart, MIBG uptake in Parkinson's disease (early H/N4: 1.668 0.325, late HIM: 1.500 &PLUSMN; 0.402) was less than that in multiple system atrophy (early H/M: 2.395 &PLUSMN; 0.186, late H/M: 2.530 &PLUSMN; 0.391) and controls (early H/M: 2.635 &PLUSMN; 0.508, late H/M: 2.575 &PLUSMN; 0.635) (early: P &LT; 0.0001, late: P &LT; 0.0001). There were no significant differences in uptake by the lung, thyroid, or liver in the three groups. Only on early images, uptake in the shoulder in multiple system atrophy (early S/M: 0.473 &PLUSMN; 0.78) and Parkinson's disease (early S/M: 0.470 &PLUSMN; 0.710) was decreased compared to that in controls (early SIM: 0.560 &PLUSMN; 0.118) (P = 0.0252). MIBG is reported to be taken up in the terminal part of sympathetic nerves and demonstrates sympathetic nerve activity, especially on late images. The cause of differences between the heart and other parts of the body remains unknown. We consider the following possibilities: (a) differences in the sympathetic nervous system between Parkinson's disease and multiple system atrophy are more subtle in organs other than the heart; (b) the cause of MIBG uptake reduction by the heart in Parkinson's disease involves factors in addition to sympathetic nervous system damage; and (c) MIBG uptake by organs other than the heart involves not only the sympathetic nervous system but also non-neuronal components. In conclusion, MIBG uptake by organs other than the heart cannot differentiate Parkinson's disease from multiple system atrophy at present. &COPY; 2005 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.autneu.2005.03.003

    Web of Science

    PubMed

    researchmap

  • The relation between visual hallucinations and visual evoked potential in Parkinson disease Reviewed

    H Matsui, F Udaka, A Tamura, M Oda, T Kubori, K Nishinaka, M Kameyama

    CLINICAL NEUROPHARMACOLOGY   28 ( 2 )   79 - 82   2005.3

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: The pathophysiology of hallucinations in Parkinson disease is poorly understood. This study investigated the relation between visual hallucination and visual evoked potentials (VEPs) in Parkinson disease.
    Methods: Nineteen patients with Parkinson disease were studied. The authors divided patients into 2 groups: patients with visual hallucinations (VH group) and those without visual hallucinations (no-VH group). VEPs using a checkerboard stimulus were recorded under a drug-five state.
    Results: On multivariate regression analysis, only the average P100 latency was selected and remained significant after the backward elimination method.
    Conclusion: The authors demonstrated a close association between visual hallucinations and elongated VEP latency in Parkinson disease. VEPs may become one of the predictors for visual hallucination.

    DOI: 10.1097/01.wnf.0000157066.50948.65

    Web of Science

    PubMed

    researchmap

  • POEMS syndrome demonstrating VEGF decrease by ticlopidine Reviewed

    H Matsui, F Udaka, T Kubori, M Oda, K Nishinaka, M Kameyama

    INTERNAL MEDICINE   43 ( 11 )   1082 - 1083   2004.11

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC INTERNAL MEDICINE  

    POEMS syndrome is a syndrome that presents with polyneuropathy, organomegaly, endocrinopathy, M-proteins and skin changes. Elevated vascular endothelial growth factor (VEGF) has recently been reported in POEMS syndrome. We report a case of POEMS syndrome with high VEGF titers. Steroid, plasmapheresis and intravenous gamma-globulin had little effect. Various immunosuppressive agents were discontinued due to side effects. Although administration of aspirin did not decrease VEGF, ticlopidine decreased VEGF significantly. This case suggests that ticlopidine is a candidate for supportive therapy in POEMS syndrome and we should measure VEGF before and after the administration of ticlopidine in other cases.

    DOI: 10.2169/internalmedicine.43.1082

    Web of Science

    PubMed

    researchmap

  • Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery Reviewed

    Hideaki Matsui, Fukashi Udaka, Masaya Oda, Tamotsu Kubori, Kazuto Nishinaka, Masakuni Kameyama

    Brain and Nerve   56 ( 4 )   351 - 354   2004.4

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    We report two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery. Patient 1 was a 72-year-old woman with Parkinson's disease, visual hallucinations and musical hallucinations. Patient 2 was a 77-year-old woman with Parkinson's disease and visual hallucinations. Both patients had severe bilateral cataracts. Though it was difficult to control their visual hallucinations with medication only, cataract surgery made them disappeared quickly. The visual hallucinations of Parkinson's disease are similar to those of Charles Bonnet syndrome. For example, both hallucinations often happen in dim light, at night and when patients are awake with eyes open. Though there have been many reports describing visual hallucinations in Parkinson's disease, there have been few reports discussing the relation between these hallucinations and impaired visual acuity. Similar to the hallucinations of Charles Bonnet syndrome, impaired visual acuity should be related to the visual hallucinations of Parkinson's disease. When Parkinson's disease, visual hallucinations and severe cataract coexist, visual hallucinations may disappear after cataract surgery.

    Scopus

    PubMed

    researchmap

▶ display all

MISC

  • パーキンソン病はリソソーム異常が原因である「Yes」の立場から

    松井秀彰

    Frontiers in Parkinson Disease   11 ( 2 )   78 - 81   2018.6

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    J-GLOBAL

    researchmap

  • 「Yes」の立場から (誌上ディベート パーキンソン病はリソソーム異常が原因である)

    松井 秀彰

    Frontiers in Parkinson disease   11 ( 2 )   78 - 81   2018.6

     More details

    Language:Japanese   Publisher:メディカルレビュー社  

    CiNii Article

    researchmap

  • 病因 その他の因子 興奮毒性

    松井秀彰

    日本臨床   76   162‐166   2018.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • アフリカメダカは老化とともにパーキンソン病に罹患する

    松井秀彰

    新潟医学会雑誌   132 ( 5 )   166 - 170   2018.5

  • 【パーキンソン病(第2版)-基礎・臨床研究のアップデート-】 病因 その他の因子 興奮毒性

    松井 秀彰

    日本臨床   76 ( 増刊4 パーキンソン病 )   162 - 166   2018.5

     More details

    Language:Japanese   Publisher:(株)日本臨床社  

    researchmap

  • αシヌクレインとそのリン酸化

    松井秀彰

    月刊メディカル・サイエンス・ダイジェスト   44 ( 3 )   172 - 173   2018.3

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    αシヌクレインは特にパーキンソン病の病態を考える上で重要な分子である。αシヌクレインが病原性を獲得する上で、何らかの翻訳後修飾が関与している可能性がある。ここではリン酸化にしぼって、その意義、そして今後の課題を概説する。(著者抄録)

    J-GLOBAL

    researchmap

  • パーキンソン病の新展開―発症の分子機構と新規治療 分子機構解明の新しい展開 小型魚類を利用したパーキンソン病モデル

    松井秀彰

    医学のあゆみ   262 ( 6 )   635‐640   2017.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • The use of fish models for Parkinson's disease research

    松井 秀彰

    医学のあゆみ   262 ( 6 )   635 - 640   2017.8

  • 小児精神疾患におけるシナプス機能異常のin vivoモデルによる可視化

    松井 秀彰

    ストレス科学研究   31 ( 0 )   88 - 89   2017.3

     More details

    Language:Japanese   Publisher:(公財)パブリックヘルスリサーチセンター  

    DOI: 10.5058/stresskagakukenkyu.31.88

    CiNii Article

    researchmap

  • 小型魚類を用いた神経精神疾患研究

    松井秀彰

    ブレインサイエンス・レビュー   2017   253 - 270   2017.2

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 生命科学を拓く新しい実験動物モデル 超短命脊椎動物アフリカメダカ

    松井 秀彰

    生体の科学   68 ( 1 )   80 - 84   2017.2

  • 小型魚類を用いた神経疾患研究

    松井秀彰, 松井秀彰

    日本神経学会学術大会プログラム・抄録集   56 ( Suppl. )   S59 - S59   2016.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    J-GLOBAL

    researchmap

  • パーキンソン病の動物モデル 最近の話題

    佐藤 栄人, 望月 秀樹, 高橋 良輔, 永井 義隆, 松井 秀彰

    Frontiers in Parkinson Disease   9 ( 1 )   5 - 13   2016.2

  • シナプス可塑性リアルタイムイメージング

    松井 秀彰

    上原記念生命科学財団研究報告集   29   1 - 3   2015.12

     More details

    Language:Japanese   Publisher:(公財)上原記念生命科学財団  

    シナプス後膜に存在するAMPA型グルタミン酸受容体(AMPA-R)を特異的に可視化することにより、シナプスの可塑的かつ動的な変化について検討した。シナプスの可塑的な変化を半定量的に可視化するために、Postsynaptic densityprotein 95(PSD95)とAMPA-Rの間接的な相互作用を利用した。ラット神経初代培養細胞において、様々な切断部位によるsplit VenusをGluA1およびPSD95に付加し、Venus再構築シグナルを経時的に比較した。ある特定のVenus切断断片を利用する場合でのみ、chemical LTP(Long-term potentiation)やchemical LTD(Long-term depression)を鋭敏に反映することが可能であった。このVenus再構築は、GluA1のCTDあるいはPSD95のPDZドメインを欠損させた場合、著明に阻害された。TARP γ-8のdelta4変異体では、複合体形成が阻害されるが、この場合もVenus再構築のシグナルは減少した。

    CiNii Article

    researchmap

  • 小型魚類の神経系のヒトとの類似と相違

    松井 秀彰

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [4T特p - 13(3P1246)]   2015.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • αシヌクレイン分解とリソソーム・オートファジー経路

    松井 秀彰

    臨床神経学   55 ( Suppl. )   S116 - S116   2015.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 小型魚類の神経系のヒトとの類似と相違

    松井 秀彰

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [4T特p - 13(3P1246)]   2015.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 【ALSとパーキンソン病-最近の進歩-】 パーキンソン病の小型魚類モデル

    松井 秀彰, 高橋 良輔

    BIO Clinica   30 ( 8 )   757 - 760   2015.8

     More details

    Language:Japanese   Publisher:(株)北隆館  

    パーキンソン病は黒質ドパミン神経の変性などを来す神経変性疾患であり、未だ原因不明である。様々な動物モデルが作製され、その病態の理解に貢献している。著者らは小型魚類の可視性と小型のサイズに注目し、パーキンソン病の小型魚類モデルを多数作製してきた。ここではそれらの概要を紹介し、病態の解明や治療薬の開発に向けた今後を展望する。(著者抄録)

    researchmap

  • Analysis of the ATP13A2mutant (PARK9) medaka (Oryzias latipes)

    TARUNO Yosuke, UEMURA Norihito, MATSUI Hideaki, YAMAKADO Hodaka, TAKAHASHI Ryosuke

    日本神経学会学術大会プログラム・抄録集   56th   537   2015

     More details

    Language:English  

    J-GLOBAL

    researchmap

  • GBA変異メダカは脳にalpha-synuclein凝集体を形成する

    上村 紀仁, 石川 智子, 木下 政人, 小池 正人, 松井 秀彰, 山門 穂高, 植村 健吾, 内山 安男, 藤堂 剛, 武田 俊一, 高橋 良輔

    臨床神経学   54 ( Suppl. )   S60 - S60   2014.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • ゼブラフィッシュ小脳のin vivoにおける機能的区域化

    松井 秀彰, 濤川 一彦, Koester Reinhard

    臨床神経学   54 ( Suppl. )   S197 - S197   2014.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • ATP13A2変異メダカの解析

    樽野 陽亮, 谷口 善仁, 松井 秀彰, 上村 紀仁, 山門 穂高, 武田 俊一, 高橋 良輔

    臨床神経学   54 ( Suppl. )   S241 - S241   2014.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • ATP13A2変異メダカの解析

    樽野 陽亮, 谷口 善仁, 松井 秀彰, 上村 紀仁, 山門 穂高, 武田 俊一, 高橋 良輔

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   8回   80 - 80   2014.10

     More details

    Language:Japanese   Publisher:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • ゼブラフィッシュを用いた神経精神疾患の創薬 (平成25年度研究奨励金受領報告) -- (細胞老化と創薬)

    松井 秀彰

    東京生化学研究会助成研究報告集   29   129 - 132   2014

     More details

    Language:Japanese   Publisher:東京生化学研究会  

    CiNii Article

    CiNii Books

    researchmap

  • GBA変異メダカは軸索内にalpha‐synucleinを蓄積する

    上村紀仁, 石川智子, 木下政人, 小池正人, 松井秀彰, 山門穂高, 内山安男, 藤堂剛, 武田俊一, 高橋良輔

    日本Cell Death学会学術集会プログラム抄録集   23rd   72   2014

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 神経変性疾患に関する調査研究 メダカを用いたGBA変異とパーキンソン病の関連性の解析

    高橋良輔, 上村紀仁, 石川智子, 木下政人, 小池正人, 松井秀彰, 山門穂高, 植村健吾, 内山安男, 藤堂剛, 武田俊一

    神経変性疾患に関する調査研究 平成25年度 総括・分担研究報告書   52 - 55   2014

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 遺伝性パーキンソン病原因遺伝子産物ATP13A2の機能解析

    佐藤 栄人, 里 史明, 小池 正人, 松井 秀彰, 舩山 学, 斉木 臣二, 金井 数明, 高橋 良輔, 内山 安男, 服部 信孝

    順天堂醫事雑誌   59 ( 6 )   534 - 534   2013.12

     More details

    Language:Japanese   Publisher:順天堂医学会  

    researchmap

  • 若年発症パーキンソン病原因遺伝子産物ATP13A2の機能解析

    佐藤 栄人, 里 史明, 松井 秀彰, 小池 正人, 金井 数明, 斉木 臣二, 舩山 学, 武田 俊一, 内山 安男, 高橋 良輔, 服部 信孝

    臨床神経学   53 ( 12 )   1525 - 1525   2013.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • ATP13A2変異メダカの解析

    樽野 陽亮, 谷口 善仁, 松井 秀彰, 上村 紀仁, 山門 穂高, 高橋 良輔

    臨床神経学   53 ( 12 )   1557 - 1557   2013.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • メダカを用いたGBA変異とパーキンソン病の関連性の解析

    上村 紀仁, 松井 秀彰, 藤原 智子, 川, 木下 政人, 小池 正人, 山門 穂高, 植村 健吾, 内山 安男, 藤堂 剛, 武田 俊一, 高橋 良輔

    臨床神経学   53 ( 12 )   1557 - 1557   2013.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 遺伝性パーキンソン病原因遺伝子産物ATP13A2の機能解析

    佐藤 栄人, 里 史明, 小池 正人, 松井 秀彰, 舩山 学, 斉木 臣二, 金井 数明, 高橋 良輔, 内山 安男, 服部 信孝

    順天堂醫事雑誌   59 ( 5 )   459 - 459   2013.10

     More details

    Language:Japanese   Publisher:順天堂医学会  

    researchmap

  • Viable Gaucher's disease model of medaka fish completely deficienct in glucocerebrosidase activity developed alpha-synuclein aggregation in the brain

    N. Uemura, H. Matsui, T. Fujiwara-Ishikawa, M. Kinoshita, M. Koike, H. Yamakado, K. Uemura, Y. Uchiyama, T. Todo, S. I. Takeda, R. Takahashi

    MOVEMENT DISORDERS   28   S373 - S374   2013.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 若年発症パーキンソン病原因遺伝子産物ATP13A2の機能解析

    SATO SHIGEHITO, SATO FUMIAKI, MATSUI HIDEAKI, KOIKE MASATO, KANAI KAZUAKI, SAIKI SHINJI, FUNAYAMA MANABU, TAKEDA SHUN'ICHI, UCHIYAMA YASUO, TAKAHASHI RYOSUKE, HATTORI NOBUTAKA

    日本神経学会学術大会プログラム・抄録集   54th   414   2013

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • メダカを用いたGBA変異とパーキンソン病の関連性の解析

    UEMURA NORIHITO, MATSUI HIDEAKI, FUJIWARA(ISHIKAWA, TOMOKO, KINOSHITA MASATO, KOIKE MASATO, YAMAKADO HOTAKA, UEMURA KENGO, UCHIYAMA YASUO, TODO TAKESHI, TAKEDA SHUN'ICHI, TAKAHASHI RYOSUKE

    日本神経学会学術大会プログラム・抄録集   54th   448   2013

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • PINK1とParkinは脊椎動物において相補的にミトコンドリアを保護する

    ASANO TAKESHI, MATSUI HIDEAKI, GAVINIO ROBERTO, UEMURA NORIHITO, ITO HIDEFUMI, TANIGUCHI YOSHIHITO, SHEN JIE, TAKEDA SHUN'ICHI, UEMURA KENGO, YAMAKADO HOTAKA, TAKAHASHI RYOSUKE

    日本Cell Death学会学術集会プログラム抄録集   22nd   66   2013

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • GBAノックアウトメダカは脳にアルファシヌクレイン凝集体を形成する

    UEMURA NORIHITO, FUJIWARA(ISHIKAWA, TOMOKO, KINOSHITA MASATO, KOIKE MASATO, MATSUI HIDEAKI, YAMAKADO HOTAKA, UEMURA KENGO, UCHIYAMA YASUO, TODO TAKESHI, TAKEDA SHUN'ICHI, TAKAHASHI RYOSUKE

    日本Cell Death学会学術集会プログラム抄録集   22nd   56   2013

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • めだかを使った遺伝子改変モデル

    松井秀彰, 高橋良輔

    月刊メディカル・サイエンス・ダイジェスト   37 ( 8 )   304 - 305   2011.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Proteasome Inhibition in Medaka Brain Induces the Features of Parkinson&apos;s Disease

    H. Matsui, H. Ito, Y. Taniguchi, H. Inoue, S. Takeda, R. Takahashi

    MOVEMENT DISORDERS   25   S623 - S623   2010.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY-LISS  

    Web of Science

    researchmap

  • パーキンソン病にはオートファジー・リソソーム系の異常が関与している(Abnormal autophagy/lysosome function may play some role in Parkinson's disease)

    松井 秀彰, 伊東 秀文, 谷口 善仁, 武田 俊一, 高橋 良輔

    神経化学   49 ( 2-3 )   488 - 488   2010.8

     More details

    Language:English   Publisher:日本神経化学会  

    researchmap

  • Abnormal autophagy/lysosome function may play some role in Parkinson's disease

    Hideaki Matsui, Hidefumi Ito, Yoshihito Taniguchi, Shunichi Takeda, Ryosuke Takahashi

    NEUROSCIENCE RESEARCH   68   E71 - E71   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.080

    Web of Science

    researchmap

  • Proteasome inhibition in medaka brain induces the features of Parkinson&apos;s disease

    R. Takahashi, H. Matsui, H. Itoh, Y. Taniguchi, H. Inoue, S. -I. Takeda

    MOVEMENT DISORDERS   25 ( 7 )   S211 - S211   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY-LISS  

    Web of Science

    researchmap

  • Parkin変異メダカとATP13A2変異メダカの解析

    松井 秀彰, 谷口 善仁, 井上 治久, 小林 芳人, 植村 健吾, 竹内 秀明, 武田 俊一, 高橋 良輔

    臨床神経学   49 ( 12 )   1005 - 1005   2009.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 『メダカを利用したパーキンソン病研究』

    松井秀彰, 松井秀彰, 谷口善仁, 谷口善仁, 井上治久, 井上治久, 竹内秀明, 植村健吾, 武田俊一, 武田俊一, 高橋良輔, 高橋良輔

    脳21   12 ( 3 )   379 - 379   2009.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • The Pathological Mechanisms of Parkinson's Disease

    MATSUI HIDEAKI, TAKAHASHI RYOSUKE

    Brain Nerve   61 ( 4 )   441 - 446   2009.4

  • The pathological mechanisms of parkinson's disease Reviewed

    Hideaki Matsui, Ryosuke Takahashi

    Brain and Nerve   61 ( 4 )   441 - 446   2009.4

     More details

    Language:Japanese   Publisher:4  

    Parkinson's disease (PD) is the second most common neurodegenerative disease. It is associated with the degeneration of dopaminergic neurons in the substantia nigra pars compacta and other areas of the brain. The pathology of PD is characterized by the accumulation of a cytoplasmic fibrillar structure, wherein α-synuclein is the major component. Most occurrences of PD were believed to be sporadic and associated with aging and environmental stress. However, there is now strong evidence for genetic inheritance in a small number of families. Although the pathological mechanisms of PD are still largely unknown, we present the major hypotheses and discuss the future directions of studies in this area.

    Scopus

    PubMed

    researchmap

  • Various models for Parkinson&apos;s disease using mutant medaka and toxin-treated medaka

    Hideaki Matsui, Yoshihito Taniguchi, Haruhisa Inoue, Shunichi Takeda, Ryosuke Takahashi

    NEUROSCIENCE RESEARCH   65   S118 - S119   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.557

    Web of Science

    researchmap

  • メダカにおけるParkinノックアウトモデルの作製

    小林 芳人, 松井 秀彰, 谷口 善仁, 植村 健吾, 井上 治久, 武田 俊一, 高橋 良輔

    臨床神経学   48 ( 12 )   1186 - 1186   2008.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • パーキンソン病メダカモデルの作製

    松井 秀彰, 谷口 善仁, 武田 俊一, 植村 健吾, 小林 芳人, 井上 治久, 高橋 良輔

    臨床神経学   48 ( 12 )   1186 - 1186   2008.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 【キーワード 蛋白質の一生】 パーキンソン病

    松井 秀彰, 高橋 良輔

    蛋白質・核酸・酵素   53 ( 8 )   981 - 981   2008.6

     More details

    Language:Japanese   Publisher:共立出版(株)  

    researchmap

  • Features of PINK1 KO medaka

    Hideaki Matsui, Yoshihito Taniguchi, Shunichi Takeda, Haruhisa Inoue, Yoshito Kobayashi, Kengo Uemura, Hideaki Takeuchi, Ryosuke Takahashi

    NEUROSCIENCE RESEARCH   61   S202 - S202   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • パーキンソン病の分子病態 3.パーキンソン病関連遺伝子:PINK1,DJ‐1,LRRK2

    松井秀彰, 高橋良輔

    実験医学   25 ( 13 )   1969 - 1973   2007.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 骨折に対するギプス固定後の、腓骨神経麻痺を契機に発見されたポリニューロパチーの1例

    小松 研一, 宇高 不可思, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   47 ( 8 )   550 - 550   2007.8

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 【脳神経疾患の分子病態と治療への展開 アルツハイマー病、パーキンソン病、発達障害、精神疾患などの発症メカニズムを分子から解く】 パーキンソン病の分子病態 パーキンソン病関連遺伝子 PINK1,DJ-1,LRRK2

    松井 秀彰, 高橋 良輔

    実験医学   25 ( 13 )   1969 - 1973   2007.8

     More details

    Language:Japanese   Publisher:(株)羊土社  

    家族性(遺伝性)パーキンソン病(PD)では次々と原因遺伝子が同定されているが、本稿ではPINK1,DJ-1,LRRK2について概説する。PINK1,DJ-1はミトコンドリア機能に関与し、アポトーシスや各種ストレスに保護的に機能をもつ。変異体ではその生理的機能が失われ、ミトコンドリア機能喪失に伴うPD発症が考えられる。LRRK2の疾患関連の変異体ではキナーゼ活性の上昇や細胞毒性が観察されgain of functionによる発症が考えられる。PINK1,DJ-1はミトコンドリア機能障害仮説を支持するという点で、LRRK2変異は家族性および孤発性PDにおいて頻度が高いという点で特に興味深く、今後の研究が待たれる。(著者抄録)

    researchmap

  • パーキンソン病における痴呆 テンソール画像による解析

    松井 秀彰, 西中 和人, 織田 雅也, 新川 秀和, 小松 研一, 久堀 保, 宇高 不可思

    臨床神経学   46 ( 12 )   1136 - 1136   2006.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 右後頭葉の複数の病変により見かけ上の左上同名四半盲を呈した心原性脳塞栓症の一例

    中野 栄子, 久堀 保, 小松 研一, 松井 秀彰, 田口 敬子, 織田 雅也, 西中 和人, 宇高 不可思, 亀山 正邦

    臨床神経学   46 ( 8 )   592 - 592   2006.8

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 脳のMRI所見と病理所見の対比検討

    宇高不可思, 西中和人, 久堀保, 織田雅也, 松井秀彰, 小松研一, 亀山正邦

    住友病院医学雑誌   ( 33 )   94 - 94   2006.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • DTIを用いたパーキンソン病における痴呆の検討

    松井 秀彰

    住友病院医学雑誌   ( 33 )   100 - 100   2006.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    researchmap

  • 「軽症」脳血管障害

    織田雅也, 松井秀彰, 久堀保, 西中和人, 宇高不可思, 亀山正邦

    住友病院医学雑誌   ( 33 )   89 - 89   2006.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 胸腺腫と重症筋無力症に合併したIsaacs’Syndrome

    松井秀彰, 宇高不可思, 西中和人, 中野栄子, 小松研一, 織田雅也, 久堀保, 亀山正邦

    住友病院医学雑誌   ( 33 )   23 - 27   2006.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • パーキンソン病における精神症状

    松井秀彰, 宇高不可思, 西中和人, 中野栄子, 小松研一, 織田雅也, 久堀保, 亀山正邦

    住友病院医学雑誌   ( 33 )   1 - 11   2006.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • STIR法にて視神経の虚血を描出し得た1例

    松井秀彰, 宇高不可思, 西中和人, 中野栄子, 小松研一, 織田雅也, 久堀保, 亀山正邦

    住友病院医学雑誌   ( 33 )   28 - 31   2006.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 脳血流から見たパーキンソン病における痴呆の多様性

    松井 秀彰, 宇高 不可思, 原 成広, 織田 雅也, 久堀 保, 西中 和人, 小松 研一, 亀山 正邦

    日本内科学会雑誌   95 ( Suppl. )   209 - 209   2006.2

     More details

    Language:Japanese   Publisher:(一社)日本内科学会  

    researchmap

  • 多発性脳梗塞による対麻ひをきたした1例

    松井秀彰, 宇高不可思, 西中和人, 久堀保, 亀山正邦

    内科   97 ( 1 )   193 - 194   2006.1

  • パーキンソン病におけるFrontal Assessment Battery(FAB)と脳血流の関係

    松井 秀彰, 宇高 不可思, 三好 崇文, 原 成広, 田村 暁子, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   45 ( 12 )   1056 - 1056   2005.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 頚椎症による首下がり

    松井秀彰, 宇高不可思, 久堀保, 織田雅也, 西中和人, 亀山正邦

    内科   96 ( 5 )   975 - 977   2005.11

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 頸椎症による首下がり

    松井 秀彰, 宇高 不可思, 久堀 保, 織田 雅也, 西中 和人, 亀山 正邦

    内科   96 ( 5 )   975 - 977   2005.11

     More details

    Language:Japanese   Publisher:(株)南江堂  

    76歳女.1ヵ月前に出現した首下がりが徐々に増悪した.頸部背屈力の低下を認めたが,他に異常所見はなかった.頸部MRIでは頸椎性変化をC4〜C6レベルに認め,表面筋電図では僧帽筋の活動増加を認めたが,胸鎖乳突筋の活動は正常であった.針筋電図では頭板状筋に線維自発電位と陽性鋭波を強く認めた.1年間の経過観察を行ったところ他の筋に症状が出ることはなく,首下がりは頸椎症によるものと診断した

    CiNii Article

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00974&link_issn=&doc_id=20051025020033&doc_link_id=issn%3D0022-1961%26volume%3D96%26issue%3D5%26spage%3D975&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0022-1961%26volume%3D96%26issue%3D5%26spage%3D975&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • 咳にて悪化する脊髄ミオクローヌスの1例

    松井秀彰, 宇高不可思, 久堀保, 織田雅也, 西中和人, 亀山正邦

    内科   96 ( 4 )   792 - 794   2005.10

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 咳にて悪化する脊髄ミオクローヌスの1例

    松井 秀彰, 宇高 不可思, 久堀 保, 織田 雅也, 西中 和人, 亀山 正邦

    内科   96 ( 4 )   792 - 794   2005.10

     More details

    Language:Japanese   Publisher:(株)南江堂  

    46歳女.咳,後頸部痛,両上肢のふるえが出現し,自然経過で約2週間で消失した.咳が再度出現し,後頸部痛悪化し,両上肢のふるえも再度出現した.頸部MRIでC6/7椎体レベルに椎間板ヘルニアを認めた.脳波,視覚誘発電位,聴性誘発反応,末梢神経伝導速度,感覚誘発電位には異常を認めなかった.diazepam,loxoprofenを適宜使用し疼痛に対処したが,軽度の効果をみるのみであった.ミオクローヌスはdiazepam処方後もしばらく変化はなかったが,咳が軽快してくるとともにミオクローヌスも軽減し,咳とともに消失した.その後も後頸部痛は軽快するものの残存し続けた

    CiNii Article

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00974&link_issn=&doc_id=20050928110035&doc_link_id=issn%3D0022-1961%26volume%3D96%26issue%3D4%26spage%3D792&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0022-1961%26volume%3D96%26issue%3D4%26spage%3D792&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • 血清MPO-ANCA陽性で皮膚病変を認めた非全身性血管炎性ニューロパチーの1例

    田村 暁子, 宇高 不可思, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   45 ( 10 )   776 - 776   2005.10

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 髄液抗カルジオリピン抗体が血清に比し遅れて陽性化した再発性脊髄炎の1例

    松井秀彰, 宇高不可思, 久堀保, 西中和人, 亀山正邦

    内科   96 ( 3 )   593 - 596   2005.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 髄液抗カルジオリピン抗体が血清に比し遅れて陽性化した再発性脊髄炎の1例

    松井 秀彰, 宇高 不可思, 久堀 保, 西中 和人, 亀山 正邦

    内科   96 ( 3 )   593 - 596   2005.9

     More details

    Language:Japanese   Publisher:(株)南江堂  

    56歳男性.患者は四肢のしびれ,両下肢の筋力低下を主訴に近医を受診,頸髄MRIにてC4〜C5レベルのT2高信号域を指摘され,著者らの施設へ入院となった.入院時,一般理学所見,皮膚所見,神経学的所見に異常はみられず,両下肢の筋力低下および筋萎縮を認めた.全血・生化学・甲状腺機能に異常はなく,抗カルジオリピン抗体と抗RNP抗体は血清で陽性であったが,髄液中では陰性であった.再発性髄膜炎と診断し,ステロイドパルス療法を行ったところ,症状および画像所見の軽快がみられた.症状軽快時の血清中の抗カルジオリピン抗体,抗RNP抗体は変化なく陽性で,更に髄液では抗カルジオリピン抗体が陽性化した

    CiNii Article

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00974&link_issn=&doc_id=20050823170038&doc_link_id=issn%3D0022-1961%26volume%3D96%26issue%3D3%26spage%3D593&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0022-1961%26volume%3D96%26issue%3D3%26spage%3D593&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • 一過性の複視に引き続き急性大動脈解離で突然死した巨細胞動脈炎の1剖検例

    松井秀彰, 宇高不可思, 織田雅也, 辻村崇浩, 亀山正邦

    内科   96 ( 2 )   383 - 385   2005.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 一過性の複視に引き続き急性大動脈解離で突然死した巨細胞動脈炎の1剖検例

    松井 秀彰, 宇高 不可思, 織田 雅也, 辻村 崇浩, 亀山 正邦

    内科   96 ( 2 )   383 - 385   2005.8

     More details

    Language:Japanese   Publisher:(株)南江堂  

    61歳男.約5年前から高血圧と気管支喘息で降圧薬を内服中,右方視時に複視を認め,脳梗塞の疑いで入院となった.入院後は複視,眼球運動障害共に消失し,血管炎を考慮し各種検査及び全身検索を行っていた.入院4日後,18時10分に食事中のところを確認されていたが,18時30分に腹臥位で心肺停止状態で発見され,蘇生処置を行うも効果なく死亡が確認された.遺族の了承と同意を得て病理解剖を行った結果,肉眼所見では急性大動脈解離を認め,死因と考えられた.顕微鏡学的所見では大動脈に巨細胞を含む炎症細胞浸潤がみられ,巨細胞動脈炎と診断した.炎症細胞浸潤は頭蓋内の左内頸動脈にもみられた

    CiNii Article

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00974&link_issn=&doc_id=20050725470033&doc_link_id=issn%3D0022-1961%26volume%3D96%26issue%3D2%26spage%3D383&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0022-1961%26volume%3D96%26issue%3D2%26spage%3D383&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • Brown‐Sequard症候群を来した黄色靭帯骨化症の1例

    林秀敏, 織田雅也, 松井秀彰, 久堀保, 西中和人, 宇高不可思, 井本和彦, 太田信彦

    住友病院医学雑誌   ( 32 )   34 - 37   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Horner症候群と左上肢の筋力低下を呈した頚髄梗塞の1例

    松井秀彰, 宇高不可思, 久堀保, 西中和人, 亀山正邦

    内科   96 ( 1 )   169 - 173   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 重症筋無力症の病型分類と眼輪筋における反復刺激試験について

    松井秀彰, 宇高不可思, 久堀保, 田村暁子, 織田雅也, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 32 )   1 - 5   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • IMP-SPECTを用いたパーキンソン病における痴呆の検討

    松井 秀彰, 宇高 不可思, 三好 崇文, 原 成広, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    認知神経科学   7 ( 2 )   165 - 165   2005.7

     More details

    Language:Japanese   Publisher:認知神経科学会  

    researchmap

  • 軽度の神経症状にて発見された裂脳症の成人例

    松井秀彰, 宇高不可思, 織田雅也, 田村暁子, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 32 )   19 - 22   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 白内障手術後に幻視の軽快したパーキンソン病の2例

    松井秀彰, 宇高不可思, 織田雅也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 32 )   73 - 73   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Parkinson病の首下がりに対するmuscle afferent blockの有用性について

    浅井宏英, 宇高不可思, 松井秀彰, 大石直也, 金本元勝, 織田雅也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 32 )   69 - 69   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 胃切除後20年して発症したビタミンB1欠乏によるポリニューロパチー

    松井秀彰, 宇高不可思, 織田雅也, 田村暁子, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 32 )   23 - 25   2005.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 症例 Horner症候群と左上肢の筋力低下を呈した頸髄梗塞の1例

    松井 秀彰, 宇高 不可思, 久堀 保

    内科   96 ( 1 )   169 - 173   2005.7

     More details

    Language:Japanese   Publisher:南江堂  

    CiNii Article

    researchmap

  • Horner症候群と左上肢の筋力低下を呈した頸髄梗塞の1例

    松井 秀彰, 宇高 不可思, 久堀 保, 西中 和人, 亀山 正邦

    内科   96 ( 1 )   169 - 173   2005.7

     More details

    Language:Japanese   Publisher:(株)南江堂  

    69歳男.左肩疼痛,左握力低下,左眼裂狭小,尿閉が出現した.浮腫はなく,神経学的には高次脳機能に異常を認めなかった.検査所見ではWBCの上昇,凝固系の亢進,TG,LDH,GGT,CKおよびCRP,C3c,CH50の上昇を認めた.頭部MRIで異常所見はなく,頸部MRIの矢状断で第4〜5頸椎レベルの頸髄にT2強調像高信号を認めた.横断面では頸髄の左側半分の前方に限局する高信号を認め,梗塞は灰白質に限局していると考えた.脊髄梗塞と診断し,尿閉に対しては尿道バルーンカテーテルを挿入すると共に,十分な補液とalprostadil 10μgを点滴し,aspirin 100mg内服を開始した.その結果,2週間後に左肩の疼痛は消失し,以後排尿,握力,瞳孔径も改善し,眼裂狭小は軽度残存するのみとなった

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00974&link_issn=&doc_id=20050708390032&doc_link_id=issn%3D0022-1961%26volume%3D96%26issue%3D1%26spage%3D169&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0022-1961%26volume%3D96%26issue%3D1%26spage%3D169&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • Brown-Sequard症候群を来した黄色靱帯骨化症の1例

    林 秀敏, 織田 雅也, 松井 秀彰, 久堀 保, 西中 和人, 宇高 不可思, 井本 和彦, 太田 信彦

    住友病院医学雑誌   ( 32 )   34 - 37   2005.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    59歳男性.患者は両大腿前面の強い疼痛を伴うしびれ感が次第に両下肢全体に拡大し,更に両前腕にも軽いしびれ感が出現,受診となった.電気生理学的検査では両側正中神経の終末潜時の遅延,両側脛骨神経のF波潜時の遅延,下肢体性感覚誘導電位で両側P40潜時の遅延を認め,画像検査が予定されていたが,臍下より両下肢へのしびれが強くなり歩行障害,膀胱直腸障害,右腰部痛を認め緊急入院となった.入院時,痙性歩行をはじめ片足立ちは両側不可能で,深部腱反射は右下肢で亢進,腹壁反応は消失,両側性にBabinski徴候,右下肢の振動覚低下,左下肢の温痛覚低下,排尿障害,便秘を認めた.胸髄MRIでは第11〜12胸椎レベルで両側の黄色靱帯が肥厚して低信号を呈し,正中型の椎間板ヘルニアを伴う著しい脊柱管の狭小化を認め,T2強調で髄内の高信号変化が確認された.一方,CTでは黄色靱帯の骨化を認め,黄色靱帯骨化症と診断し,手術適応と考え,以後,整形外科へ転科となった

    researchmap

  • パーキンソン病の首下がりに対するmuscle afferent blockの有効性について

    浅井宏英, 宇高不可志, 久堀保, 松井秀彰, 織田雅也, 西中和人, 亀山正邦

    総合リハビリテーション   33 ( 6 )   557 - 561   2005.6

  • 神経疾患長期罹病患者における上腸間膜動脈症候群の合併

    織田 雅也, 宇高 不可思, 西中 和人, 田村 暁子, 松井 秀彰, 久堀 保, 亀山 正邦

    神経治療学   22 ( 3 )   397 - 397   2005.5

     More details

    Language:Japanese   Publisher:日本神経治療学会  

    researchmap

  • 失神を生じた頭頸部主幹動脈閉塞症例の検討

    織田 雅也, 宇高 不可思, 西中 和人, 田村 暁子, 松井 秀彰, 久堀 保, 亀山 正邦, 松澤 佑次

    日本内科学会雑誌   94 ( Suppl. )   166 - 166   2005.2

     More details

    Language:Japanese   Publisher:(一社)日本内科学会  

    researchmap

  • Pramipexole induced leukopenia in Parkinson's disease.

    MATSUI HIDEAKI, UDAKA FUKASHI, ODA MASAYA, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    月刊神経内科   62 ( 2 )   152 - 154   2005.2

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • パーキンソン病における幻視の危険因子としての視力低下について

    松井 秀彰, 宇高 不可思, 田村 暁子, 織田 雅也, 久堀 保, 西中 和人, 松澤 佑次, 亀山 正邦

    日本内科学会雑誌   94 ( Suppl. )   255 - 255   2005.2

     More details

    Language:Japanese   Publisher:(一社)日本内科学会  

    researchmap

  • ミオクローヌス出現肢と同側半球がてんかん波の発生源と考えられたfamilial essential myoclonus and epilepsyの一例

    浅井 宏英, 宇高 不可思, 金本 元勝, 松井 秀彰, 大石 直也, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   45 ( 2 )   181 - 181   2005.2

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • A case of Parkinson disease with sleep attack occurring in the presence of the chief doctor

    MATSUI HIDEAKI, UDAKA FUKASHI, KUBORI TAMOTSU, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    月刊神経内科   62 ( 1 )   83 - 86   2005.1

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 進行期Parkinson病におけるMosapride大量療法の効果について

    浅井 宏英, 宇高 不可思, 金本 元勝, 松井 秀彰, 大石 直也, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   44 ( 12 )   1183 - 1183   2004.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • パーキンソン病患者における前頭葉簡易機能検査(FAB) 脳血流画像を用いた検討

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   44 ( 12 )   1115 - 1115   2004.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 足趾への電気刺激による指尖部の皮膚温度変化の検討

    久堀 保, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 大石 直也, 織田 雅也, 西中 和人, 亀山 正邦

    臨床神経学   44 ( 12 )   1128 - 1128   2004.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • A case of neurosyphilis.

    MATSUI HIDEAKI, UDAKA FUKASHI, KUBORI TAMOTSU, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    月刊神経内科   61 ( 5 )   463 - 466   2004.11

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 抗SGPG抗体陽性neuropathyの経過中に中枢神経系への浸潤を伴った悪性リンパ腫の1例

    浅井 宏英, 宇高 不可思, 松井 秀彰, 大石 直也, 金本 元勝, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   44 ( 10 )   733 - 733   2004.10

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • Fluvoxamineにて軽快した高齢女性の口腔内セネストパチー

    松井 秀彰, 宇高 不可思, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    老年精神医学雑誌   15 ( 9 )   1065 - 10695   2004.9

     More details

    Language:Japanese   Publisher:(株)ワールドプランニング  

    フルボキサミンにて軽快した高齢女性(81歳)の口腔内セネストパチー症例を報告した.患者には特に精神科疾患の家族歴や既往歴,現病は認めなかった.口がねばる,口の中からどろどろした流動物が出てくるという訴えを示すようになった.歯科,耳鼻咽喉科,内科にて精査したが異常はなく,口腔セネストパチーと診断され,スルピリドを処方したが,効果を得られず中止した.その後,フルボキサミン25mgを使用したところ,症状は完全には消失しないものの苦痛であることはなくなった

    CiNii Article

    J-GLOBAL

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2004&ichushi_jid=J02464&link_issn=&doc_id=20041001010009&doc_link_id=%2Faj2rsizd%2F2004%2F001509%2F010%2F1065-1069%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faj2rsizd%2F2004%2F001509%2F010%2F1065-1069%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • L‐dopa増量に伴いパ二ック発作を引き起こしたパーキンソン病の2症例

    松井秀彰, 宇高不可思, 三好崇文, 織田雅也, 西中和人, 亀山正邦

    臨床精神医学   33 ( 8 )   1055 - 1059   2004.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • L-dopa-induced and cabergoline-responsive retrocollis in a case of Parkinson disease.

    MATSUI HIDEAKI, UDAKA FUKASHI, KUBORI TAMOTSU, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    月刊神経内科   61 ( 2 )   171 - 174   2004.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • アルプラゾラムが著効したParkinson病におけるバリスムタイプのdiphasicジスキネジア

    松井秀彰, 宇高不可思, 織田雅也, 西中和人, 亀山正邦

    月刊神経内科   61 ( 2 )   217 - 218   2004.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • L-dopa増量に伴いパニック発作を引き起こしたパーキンソン病の2症例

    松井 秀彰, 宇高 不可思, 三好 崇文, 織田 雅也, 西中 和人, 亀山 正邦

    臨床精神医学   33 ( 8 )   1055 - 1059   2004.8

     More details

    Language:Japanese   Publisher:(株)アークメディア  

    L-dopa増量に伴いパニック発作を引き起こしたパーキンソン病の2症例を報告した.症例1(72歳女性)では増量に伴い,on相とoff相におけるL-dopa血中濃度の差が大きくなり,off相の時に発作が起きたことが血中濃度測定により判明した.一方,症例2(71歳女性)ではジスキネジアを伴うことやL-dopaの内服時間との関連より,L-dopaの増量によりon相におけるL-dopa血中濃度がさらに増加しon相に発作が起きたと考えられた.両症例ともL-dopaを減量することによりパニック発作は速やかに消失した.パーキンソン病に伴って起こるパニック発作では日内変動との相関を把握することが重要であるが,それが困難な場合には血中濃度の測定やL-dopa増量・減量が役立つと示唆された

    CiNii Article

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2004&ichushi_jid=J01552&link_issn=&doc_id=20040812070011&doc_link_id=%2Fao1clphd%2F2004%2F003308%2F011%2F1055-1059%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fao1clphd%2F2004%2F003308%2F011%2F1055-1059%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • えん下障害による摂食量の低下に関わらず,安静時エネルギー代謝のこう進がみられたパーキンソン病の1例―パーキンソン病の痩せについての考察―

    浅井宏英, 宇高不可思, 松井秀彰, 織田雅也, 金本元勝, 大石直也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 31 )   37 - 41   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • パーキンソン病患者における前頭葉簡易機能検査(FAB) 脳血流画像を用いた検討

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    住友病院医学雑誌   ( 31 )   93 - 93   2004.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    researchmap

  • Parkinson disease with kubisagari.

    MATSUI HIDEAKI, UDAKA FUKASHI, KUBORI TAMOTSU, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    月刊神経内科   61 ( 1 )   94 - 98   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 自律神経疾患をきたす神経疾患における胃排出能(gastric emptying)の検討

    浅井宏英, 宇高不可思, 金本元勝, 松井秀彰, 大石直也, 織田雅也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 31 )   87 - 88   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 79歳で首下がりで発症した多系統萎縮症の1例

    松井秀彰, 宇高不可思, 大石直也, 織田雅也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 31 )   26 - 29   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • A case of Parkinson disease with reflex sympathetic dystrophy and dystonia.

    MATSUI HIDEAKI, UDAKA FUKASHI, OISHI NAOYA, KUBORI TAMOTSU, KAMEYAMA MASAKUNI

    月刊神経内科   61 ( 1 )   111 - 113   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • パーキンソン病の首下がり

    松井秀彰, 宇高不可思, 久堀保, 織田雅也, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 31 )   1 - 4   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • MRI拡散強調像による放線冠領域の身体部位的局在の検討

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    住友病院医学雑誌   ( 31 )   92 - 93   2004.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    researchmap

  • 髄液中Adenosine Deaminaseアイソザイムの測定が補助診断に有効であった結核性髄膜炎の1例

    浅井宏英, 宇高不可思, 松井秀彰, 織田雅也, 金本元勝, 大石直也, 久堀保, 西中和人, 井上妙

    住友病院医学雑誌   ( 31 )   21 - 25   2004.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 嚥下障害による摂食量の低下に関わらず,安静時エネルギー代謝の亢進がみられたパーキンソン病の1例 パーキンソン病の痩せについての考察

    浅井 宏英, 宇高 不可思, 松井 秀彰, 織田 雅也, 金本 元勝, 大石 直也, 久堀 保, 西中 和人, 亀山 正邦

    住友病院医学雑誌   ( 31 )   37 - 41   2004.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    70歳女性.患者は60歳時にパーキンソン病と診断され,62歳時よりL-dopa製剤やdopamine agonist投与にて経過中であったが,嚥下障害,誤嚥性肺炎,体重減少が出現し,著者らの施設へ入院となった.入院時,著明な嚥下障害による摂食不良,両手足・下顎の安静時振戦,四肢の著明な筋萎縮を認め,肺炎軽快後の安静時基礎代謝では亢進がみられた.体重減少および振戦の緩和目的でβblocker 20mg/日を計7日間投与したところ,振戦およびパーキンソニズムに変化はみられなかったが,基礎代謝量の減少および体重の増加が得られた

    researchmap

  • 幻覚を伴うパーキンソン病の脳血流 3D-SSPによる検討

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    住友病院医学雑誌   ( 31 )   93 - 93   2004.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    researchmap

  • A case of Parkinson's disease with kubisagari that developed acutely following cabergoline increase and disappeared after L-dopa increase.

    MATSUI HIDEAKI, UDAKA FUKASHI, KUBORI TAMOTSU, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    月刊神経内科   60 ( 6 )   658 - 661   2004.6

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 2.Parkinson病の首下がりに対するmuscle afferent blockの有用性について(第16回日本リハビリテーション医学会近畿地方会)

    浅井 宏英, 宇高 不可思, 松井 秀彰, 大石 直也, 金本 元勝, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    リハビリテーション医学 : 日本リハビリテーション医学会誌   41 ( 5 )   2004.5

     More details

    Language:Japanese   Publisher:社団法人日本リハビリテーション医学会  

    CiNii Article

    researchmap

  • 神経因性膀胱を有する神経難病長期罹病患者における後腹膜膿瘍の合併

    織田 雅也, 宇高 不可思, 西中 和人, 金本 元勝, 松井 秀彰, 浅井 宏英, 大石 直也, 久堀 保, 亀山 正邦

    神経治療学   21 ( 3 )   312 - 312   2004.5

     More details

    Language:Japanese   Publisher:日本神経治療学会  

    researchmap

  • Parkinson病の首下がりに対するmuscle afferent blockの有用性について

    浅井 宏英, 宇高 不可思, 松井 秀彰, 大石 直也, 金本 元勝, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    リハビリテーション医学   41 ( 5 )   324 - 324   2004.5

  • Two Cases of Parkinson's Disease in which Visual Hallucinations Disappeared after Cataract Surgery Reviewed

    MATSUI HIDEAKI, UDAKA FUKASHI, ODA MASAYA, KUBORI TAMOTSU, NISHINAKA KAZUTO, KAMEYAMA MASAKUNI

    Brain Nerve   56 ( 4 )   351 - 354   2004.4

     More details

    Language:Japanese   Publisher:4  

    PubMed

    J-GLOBAL

    researchmap

  • 白内障手術後に幻視の軽快したパーキンソン病の2例

    松井 秀彰, 宇高 不可思, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    脳と神経   56 ( 4 )   351 - 354   2004.4

     More details

    Language:Japanese   Publisher:(株)医学書院  

    症例1:72歳女.音楽性幻聴,振戦,歩行障害が出現しパーキンソン病の診断で薬物投与され症状は軽快した.しかし,その後は悪化しては薬物調節にて軽快するということを繰り返しており,幻視も出現してきた.症例2:77歳女.すりあし歩行,前傾姿勢,四肢の振戦が出現しパーキンソン病と診断された.薬物調節により経過良好であったが,幻視が出現しパーキンソン症状も悪化した.2症例とも薬剤の調節では幻視を消失させることが困難であった.両例とも重度の白内障を両眼に認めたため白内障手術を両眼ともに行ったところ,術直後より幻視は完全に消失した.パーキンソン病やCharles Bonnet症候群の幻視が,良好な視機能を持っている場合や,明るい所,閉眼時や明りのない暗闇では起こりにくく,開眼時の薄明りのもとで起こりやすいことを支持する結果となった.パーキンソン病においても幻視の出現に末梢性の視機能障害が関与している例があり,白内障合併症例では白内障手術が幻視の治療の一つの選択肢であると考えられた

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2004&ichushi_jid=J01231&link_issn=&doc_id=20040615360010&doc_link_id=10.11477%2Fmf.1406100274&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1406100274&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

  • Two Cases of Parkinson's Disease in which Visual Hallucination Disappeared after Cataract Surgery

    松井 秀彰, 宇高 不可思, 織田 雅也

    Brain and nerve : 神経研究の進歩   56 ( 4 )   351 - 354   2004.4

     More details

    Language:Japanese   Publisher:医学書院  

    CiNii Article

    researchmap

  • 副交感神経の脱神経過敏を認めたpure autonomic failureの一例

    浅井 宏英, 宇高 不可思, 松井 秀彰, 大石 直也, 金本 元勝, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   44 ( 3 )   222 - 222   2004.3

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 自発性低下で発症,両側対称性に広範な白質病変を呈したSLE脳症の1例

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   44 ( 3 )   219 - 219   2004.3

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 味覚障害で発症,Cytomegalovirus感染に関連したGuillain-Barre症候群の1例

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    臨床神経学   43 ( 8 )   521 - 521   2003.8

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 歯痛で発症し,三叉神経領域の中枢性とう痛を呈した橋梗塞の1例

    大石直也, 宇高不可思, 金本元勝, 浅井宏英, 松井秀彰, 織田雅也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 30 )   65 - 68   2003.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 両側外転神経麻ひおよび左顔面神経麻ひを認めた神経サルコイドーシスの1例

    浅井宏英, 西中和人, 松井秀彰, 香川智子, 斎藤則充, 重松三知夫, SON Y, 原吉幸, 亀山正邦

    住友病院医学雑誌   ( 30 )   51 - 55   2003.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 両側外転神経麻痺及び左顔面神経麻痺を認めた神経サルコイドーシスの1例

    浅井 宏英, 宇高 不可思, 織田 雅也, 金本 元勝, 大石 直也, 久堀 保, 西中 和人, 松井 秀彰, 香川 智子, 斎藤 則充, 重松 三知夫, 孫 権裕, 原 吉幸, 亀山 正邦

    住友病院医学雑誌   ( 30 )   51 - 55   2003.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    77歳女.10年前より糖尿病を指摘され,インスリンを導入された.左顔面神経麻痺と診断され,ステロイドの点滴治療を受け,1週間で症状は消失した.原因不明のブドウ膜炎と診断され,ステロイドの点滴を受け軽快した.胸部レントゲンで両側肺門リンパ節の腫脹(BHL)が疑われ,胸部CTを施行されたが,BHLは認められなかった.左眼部の違和感が出現し,左方視で複視が出現した.左顔半分が動きにくくなり,食事をすると左の口から物がこぼれる,左目が閉じにくくなる等の症状が出現した.ブドウ膜炎と診断され,更に眼球運動障害が認められた.胸部CTで両側肺門及び縦隔リンパ節の腫脹を認め,経気管支肺生検でサルコイド結節が認められた.神経サルコイドーシスと診断し,ステロイド治療を開始した.ステロイド開始直後に右外転神経麻痺を呈したが,ステロイドパルス療法により改善した.左顔面神経麻痺及び左外転神経麻痺は変化を認めなかった

    researchmap

  • 歯痛で発症し,三叉神経領域の中枢性疼痛を呈した橋梗塞の1例

    大石 直也, 宇高 不可思, 金本 元勝, 浅井 宏英, 松井 秀彰, 織田 雅也, 久堀 保, 西中 和人, 亀山 正邦

    住友病院医学雑誌   ( 30 )   65 - 68   2003.7

     More details

    Language:Japanese   Publisher:(一財)住友病院  

    66歳男.右側の歯及び歯肉痛を自覚した.頭部MRIなどから脳梗塞と診断された.疼痛部位が口腔内及び右側顔面部にまで拡大した.薬物療法による疼痛の改善が乏しいため,精査及び加療目的で入院した.神経学的には,口腔内を中心とする右側顔面の疼痛及び冷覚過敏が認められた.頭部MRIで右橋被蓋部背外側から右中小脳脚にかけてT2強調像及びFLAIR像で高信号病変が認められた.右側星状神経節ブロックと併行して,ノリトリプチリンを開始した.血液検査などで副作用がないことを確認しながら徐々に増量した.当初の疼痛を10とすると,最終的な疼痛が6〜7程度にまで改善した

    researchmap

  • 小脳梗塞を合併し,筋緊張の減弱を示した悪性症候群の1例

    大石直也, 宇高不可思, 金本元勝, 浅井宏英, 松井秀彰, 織田雅也, 久堀保, 西中和人, 亀山正邦

    住友病院医学雑誌   ( 30 )   69 - 73   2003.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 著明な大脳皮質静脈系の流出障害を認めたIntravascular lymphomatosis(IVL)の一例

    松井 秀彰, 柴田 益成, 景山 卓, 冨本 秀和, 池田 昭夫, 柴崎 浩

    臨床神経学   41 ( 10 )   736 - 736   2001.10

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

▶ display all

Presentations

▶ display all

Awards

  • 学長賞

    2021   新潟大学  

     More details

  • 学長賞

    2020   新潟大学  

     More details

  • Japan Neuroscience Society Young Investigator Award

    2016   Japan Neuroscience Society  

    Hideaki Matsui

     More details

  • 研究教授

    2016   新潟大学  

    松井 秀彰

     More details

  • Alexander von Humboldt Fellowship

    2011.1   Alexander von Humboldt Foundation  

    Hideaki Matsui

     More details

  • Best Poster Award

    2005.8  

    Hideaki Matsui

     More details

▶ display all

Research Projects

  • 老化における細胞外廃棄の生理学、およびその破綻による加齢関連疾患の病態生理学

    2023.10 - 2029.3

    System name:革新的先端研究開発支援事業

    Research category:AMED-CREST

    Awarding organization:AMED

      More details

    Authorship:Principal investigator 

    researchmap

  • APPとαシヌクレインの生理機能に立脚したアルツハイマーとパーキンソンのシン病態

    Grant number:23K17421

    2023.6 - 2026.3

    System name:科学研究費助成事業

    Research category:挑戦的研究(開拓)

    Awarding organization:日本学術振興会

    松井 秀彰

      More details

    Grant amount:\26000000 ( Direct Cost: \20000000 、 Indirect Cost:\6000000 )

    researchmap

  • 異所性のDNAがもたらす老化・加齢関連疾患・感染症病態の網羅的比較解析

    Grant number:22H00501

    2022.4 - 2027.3

    System name:科学研究費助成事業

    Research category:基盤研究(A)

    Awarding organization:日本学術振興会

    松井 秀彰, 垣花 太一, 渡邉 香奈子

      More details

    Grant amount:\41860000 ( Direct Cost: \32200000 、 Indirect Cost:\9660000 )

    researchmap

  • Application of the Autonomic Nervous Management for NAFLD Treatment

    Grant number:21K19478

    2021.7 - 2024.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Challenging Research (Exploratory)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\6500000 ( Direct Cost: \5000000 、 Indirect Cost:\1500000 )

    researchmap

  • 臓器連関の包括的理解に基づく認知症関連疾患の克服に向けて

    2021.4

    System name:ムーンショット目標2

    Awarding organization:JST

      More details

  • ミトコンドリアDNAの漏出が起こす個体機能低下及び諸臓器の加齢関連疾患の解析

    2019.10 - 2023.3

    System name:革新的先端研究開発支援事業PRIME

    Awarding organization:AMED

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 異所性のミトコンドリアDNAを処理することによる二大認知症の治療探索

    2019.9 - 2021.3

    System name:脳科学研究戦略推進プログラム

    Awarding organization:AMED

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Neurodegeneration induced by ectopic mitochondrial DNA

    Grant number:18H02716

    2018.4 - 2021.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

    Matsui Hideaki

      More details

    Grant amount:\17550000 ( Direct Cost: \13500000 、 Indirect Cost:\4050000 )

    In this study, we showed that mitochondrial DNA leaks into the cytoplasm in cultured cells and zebrafish that mimic the state of Parkinson's disease. It was also shown that the inflammatory reaction and neurodegeneration are improved by inhibiting the sensor of mitochondrial DNA leaked into the cytoplasm and promoting the degradation of cytoplasmic mitochondrial DNA. In addition, mitochondrial DNA leaked into the cytoplasm and its sensor IFI16 were accumulated in PD brains. These results suggest that cytoplasmic leakage of mitochondrial DNA may be an important cause of neurodegeneration in Parkinson's disease.

    researchmap

  • 超短命アフリカメダカで明らかにするパーキンソン病の新たな病態

    2018

    System name:ビジョナリーリサーチ継続助成(ステップ)

    Awarding organization:武田科学振興財団

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • αシヌクレイン老化が引き起こす個体老化パーキンソン病

    2017.4 - 2019.3

    System name:新学術領域研究(研究領域提案型)

    Awarding organization:文部科学省

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • αシヌクレイン老化が引き起こす個体老化パーキンソン病

    Grant number:17H05692

    2017.4 - 2019.3

    System name:科学研究費助成事業 新学術領域研究(研究領域提案型)

    Research category:新学術領域研究(研究領域提案型)

    Awarding organization:日本学術振興会

    松井 秀彰

      More details

    Grant amount:\10660000 ( Direct Cost: \8200000 、 Indirect Cost:\2460000 )

    パーキンソン病(PD)はその発症に老化が強く関連しています。モザンビークに棲息するアフリカメダカは脊椎動物で現在最も短命でありながら非常に早期に老化の兆候を呈します。この約5ヶ月で短い一生を終えるサイクルは内因的なもので、このサイクルは野生のみならず実験室内でも再現されます。さらに加齢に伴い、臓器の萎縮、運動能力の低下、脊柱彎曲、癌の発生頻度の上昇、テロメアの短縮、老化関連酸性β-ガラクトシダーゼの上昇など、老化の様々な兆候を示します。私達は”寿命最短・最速老化”脊椎動物=アフリカメダカが加齢によりヒトPDに類似した病態を呈するかどうかを検討しました。その結果この老化が抑制されない魚の中で、加齢以外なんら特別な処置なしに、ヒトPDに酷似した病変が進んでいくことを見いだしました。すなわちアフリカメダカは加齢依存性にドパミン・ノルアドレナリン神経の変性を示し、αシヌクレイン陽性の凝集体病変は神経系の局所から全中枢神経へ連続的に進展を見せました。またアフリカメダカのαシヌクレインはヒトαシヌクレインに対する伝搬性を持っていました。さらにアフリカメダカにおけるドパミン・ノルアドレナリン神経の変性は加齢及びαシヌクレイン依存性でした。今後はさらにアフリカメダカで知見を累積し、それをマウスやヒトにあてはめ、ヒトにおいても同様に、疾患発症初期あるいは発症前に、パーキンソン病の発症を抑止できるかどうかを臨床的に検討するに十分なエビデンスを得ます。またαシヌクレインの伝搬様式および細胞変性のメカニズムを明らかにすることでPD病変の開始・伝搬および進行・細胞変性、その全ての段階での治療介入を目指します。

    researchmap

  • 実験動物アフリカメダカ:老化が抑制されないその魚は自然にパーキンソン病を発症する

    2016.4 - 2018.3

    System name:挑戦的萌芽研究

    Awarding organization:文部科学省

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • African killifish discloses Parkinson-like phenotypes during aging.

    Grant number:16K14597

    2016.4 - 2018.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Challenging Exploratory Research

    Awarding organization:Japan Society for the Promotion of Science

    Matsui Hideaki

      More details

    Grant amount:\3770000 ( Direct Cost: \2900000 、 Indirect Cost:\870000 )

    Short-lived african killifish disclosed Parkinson-like phenotypes during aging. By utilizing this fish, we showed that propagation of alpha-synuclein of this fish. Dissection of the nervous system or depletion of alpha-synuclein ameliorated Parkinson-like neurodegeneration in this fish.

    researchmap

  • 超短命アフリカメダカは神経疾患モデルとなり得るか?

    2016

    System name:ビジョナリーリサーチ継続助成(ホップ)

    Awarding organization:武田科学振興財団

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • In vivo imaging of synaptic plasticity

    Grant number:15H05571

    2015.4 - 2018.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Young Scientists (A)

    Awarding organization:Japan Society for the Promotion of Science

    Matsui Hideaki

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\22100000 ( Direct Cost: \17000000 、 Indirect Cost:\5100000 )

    In this study, we aimed to visualize AMPA receptor specifically at the post synaptic membrane and to observe and monitor the plastic and dynamic changes of synaptic functions. In primary neurons, our indicator successfully enables visualization of synaptic functions during chemical LTP or LTD. We have continued to utilize this indicator for hippocampal slice and zebrafish in vivo.

    researchmap

  • Can short-lived African medaka be a model of neuropsychiatric disease ?

    Grant number:26640061

    2014.4 - 2016.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Challenging Exploratory Research

    Awarding organization:Japan Society for the Promotion of Science

    Matsui Hideaki

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    In this research project, we found that Africa medaka (short-lived vertebrate) showed Parkinson-like pathology in age-dependent manner. This phenotype was not caused by genetic manipulation or toxin exposure but by aging. This medaka showed neurodegeneration and progression of alpha-synuclein pathology in older stage. This phenotype is very similar to human Parkinson disease phenotype.

    researchmap

  • 小型魚類を用いたシナプス可塑性のin vivoイメージング

    2013.8 - 2015.3

    System name:研究活動スタート支援

    Awarding organization:文部科学省

    松井 秀彰

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 小型魚類を用いたシナプス可塑性のin vivoイメージング

    Grant number:25890015

    2013.8 - 2015.3

    System name:科学研究費助成事業 研究活動スタート支援

    Research category:研究活動スタート支援

    Awarding organization:日本学術振興会

    松井 秀彰

      More details

    Grant amount:\1560000 ( Direct Cost: \1200000 、 Indirect Cost:\360000 )

    AMPA-Rは、長期増強(Long-term potentiation: LTP)において、シナプス後膜においてその数が増加することが指摘されており、実際にシナプス可塑性の主要な一因を果たしていると考えられている。その数の増加は、同受容体の細胞内から細胞外への挿入とそれに続く側方拡散によってシナプス後膜に集積することによってなされる。つまりシナプス後膜に特異的に集簇したAMPA-Rを標識することでシナプス可塑性をモニターすることが可能である。
    そのためにシナプス後膜に存在し、AMPA-Rと複合体を形成するタンパク質PSD-95を利用した。PSD95の近傍にあるAMPA-Rのみを可視化することができれば、シナプス後膜特異的にAMPA-Rを半定量することが可能である。特定部位で切断したVenusの断片をそれぞれAMPA-R とPSD95 に結合させたものを作製し、HEK細胞やラットの初代神経細胞にそれらを共発現させた。AMPA-RとPSD95が近傍に位置し複合体を形成すれば、Venusタンパクが再構築され蛍光を発するはずである。
    初年度はHEK細胞ならびにラット神経初代培養細胞を用いて、chemical LTDおよびchemical LTPにてこのシステムが働くことを確認した。具体的にはsplit Venusを付属させたAMPA-RとPSD-95が神経細胞内で正常なlocalizationをとること、また両者がcolocalizationする箇所のみVenusの信号が確認される事を確認した。さらにVenusの切断部位を様々に検討し、LTDおよびLTPの同定に最適な切断部位を同定した。その結果chemical LTDおよびchemical LTPに対して鋭敏に反応する組み合わせを見いだす事に成功した。現在はゼブラフィッシュの樹立中である。

    researchmap

▶ display all

 

Teaching Experience (researchmap)

Teaching Experience

  • 先端医科学研究概説

    2023
    Institution name:新潟大学